Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE006914 |
ID: | TCMBANKHE006914 |
植物拉丁名: |
|
功能与主治: | For activating blood and modulating period/Concretion and conglomeration, pain in heart and abdomen, amenorrhea, dysmenorrhea, postpartum stasis stagnation abdominal pain, retention of lochia, mounting qi , joint running impediment pain, swelling of sores, painful wound from knocks and falls, burns and scalds, poisonous snake bite. |
药用植物名: | 鬼箭羽 |
药用部位: | Euonymus alatus(Thunb.) Sieb |
药味: | Cold; Bitter |
经络: | Liver |
治疗类型: | 活血祛瘀药 |
TCM_ID_id: | 5255;7075 |
SymMap_id: | 153 |
TCMSP_id: | 300 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000023 | acetyl-11-keto-β-boswellicacid | acetyl 11-keto-β-boswellic acid | C32H48O5 | ||
| TCMBANKIN000065 | dioscin | LMST01080053; C08897; 3-O-(Rhaa1-4(Rhaa1-2)Glcb)-(25R)-spirost-5-en-3beta-ol; dioscin ; 19057-60-4; Dioscin | C45H72O16 | 869.04 | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)C)O)O)O)O)OC9C(C(C(C(O9)C)O)O)O)C)C)C)OC1 |
| TCMBANKIN000869 | syringeresinol | ||||
| TCMBANKIN000962 | campesterol | campesterol ; FT-0082089; Augelicincampesterol; (24R)-5-Ergosten-3; (1R,3AS,3BR,9AS,9BS,11AR)-1-[(2R,5R)-5,6-DIMETHYLHEPTAN-2-YL]-9A,11A-DIMETHYL-1H,2H,3H,3AH,3BH,4H,5H,5AH,6H,9H,9BH,10H,11H-CYCLOPENTA[A]PHENANTHREN-7-OL; A-ol; 24(R)-Ergost-5-en-3beta-ol; 24alpha-Methyl-5-cholesten-3beta-ol; AK307302; SC-66911; (8R,9S,10S,13R,14S,17R)-17-((2R,5R)-5,6-Dimethylheptan-2-yl)-10,13-dimethyl-4,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol; AKOS027320474; MFCD00010475; Campesterin; MolPort-035-882-175 | C28H48O | 400.68 | CC(C)C(C)CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C |
| TCMBANKIN001688 | 11-keto-β-boswellic acid | C30H46O4 | CC1CCC2(CCC3(C(=CC(=O)C4C3(CCC5C4(CCC(C5(C)C(=O)O)O)C)C)C2C1C)C)C | ||
| TCMBANKIN002067 | methyl 2,4-dimethoxy-6-methylbenzoate | Benzoic acid, 2,4-dimethoxy-6-methyl-, methyl ester; ST5408056; methyl 2,4-dimethoxy-6-methyl-benzoate; 2,4-dimethoxy-6-methylbenzoic acid methyl ester; o-Toluic acid, 4,6-dimethoxy-, methyl ester; 2,4-dimethoxy-6-methyl-benzoic acid methyl ester; ZINC02149958 | C11H14O4 | 210.23 | CC1=CC(=CC(=C1C(=O)OC)OC)OC |
| TCMBANKIN002465 | (2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one | BB_NC-1001; (2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-chromanone; ZINC00001785 | C15H12O5 | 272.25 | |
| TCMBANKIN002765 | osladin | C45H74O17 | 887.1 g/mol | CC1CCC(OC1OC2C(C(C(C(O2)C)O)O)O)C(C)C3CCC4C3(CCC5C4CC(=O)C6C5(CCC(C6)OC7C(C(C(C(O7)CO)O)O)OC8C(C(C(C(O8)C)O)O)O)C)C | |
| TCMBANKIN004137 | 11- carbonyl-p- frankincense acid | ||||
| TCMBANKIN004463 | 3,5,7,2',6'-pentahydroxy flavonol | C15H12O8 | 320.25 g/mol | C1=CC(=C(C(=C1)O)C2C(C(=O)C3=C(C=C(C=C3O2)O)O)(O)O)O | |
| TCMBANKIN004578 | 7,3',4'-Trihydroxyflavone | BRN 0253031; CHEMBL301624; AK112316; 4H-1-Benzopyran-4-one,2-(3,4-dihydroxyphenyl)-7-hydroxy-; 3',4',7-Trihydroxyflavone; LMPK12110042; DTXSID30175836; Q-100553; MolPort-004-955-148; 2-(3,4-Dihydroxy-phenyl)-7-hydroxy-chromen-4-one; trihydroxyflavone, 3',4',7-(rg); AJ-55730; 2-(3,4-dihydroxyphenyl)-7-hydroxy-4H-chromen-4-one; ZINC6092199; 5-18-04-00590 (Beilstein Handbook Reference); ZINC00057766; AX8110111; 3',4',7-Trihydroxyflavon; 2-(3,4-dihydroxyphenyl)-7-hydroxy-4-chromenone; 15Z; trihydroxyflavone, 7,3',4'-; 4CN-2593; 7, 3',4'-Trihydroxyflavone; FT-0634068; 7,3',4'-trihydroxyflavone; Flavone, 7,3',4'-trihydroxy-; BDBM50077325; D0YJ3Q; 3',4',7- TRIHYDROXY FLAVONE; 2-(3,4-dihydroxyphenyl)-7-hydroxychromen-4-one; 2-(3,4-dihydroxyphenyl)-7-hydroxy-chromen-4-one; 104666-14-0; 7,3'',4''-Trihydroxyflavone; KB-221430; 0937AB; LS-39609; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-7-hydroxy-; DB-045596; 2-(3,4-dihydroxyphenyl)-7-hydroxy-chromone; 4hlf; MCULE-1703428892; 3'',4'',7-trihydroxyflavon; AC1NT15U; MFCD00017434; 2-(3,4-dihydroxyphenyl)-7-hydroxy-4h-1-benzopyran-4-on; 2150-11-0; C-57753; PVFGJHYLIHMCQD-UHFFFAOYSA-N; ST24039238; AKOS016009456; SCHEMBL34405; 2-(3,4-Dihydroxyphenyl)-7-hydroxy-4H-1-benzopyran-4-one; ST056259; 7,3/',4/'-Trihydroxyflavone; CTK4E6984; 3',4',7 - Trihydroxyflavone | C15H10O5 | 270.24 | C1=CC(=C(C=C1C2=CC(=O)C3=C(O2)C=C(C=C3)O)O)O |
| TCMBANKIN006840 | epifriedelino1 | ||||
| TCMBANKIN006962 | 3β,16α,21β,22α,28-penahydroxyolean-12-ene-28-O-β-D-xylopyranoside | 636.91 | |||
| TCMBANKIN007307 | alatamine | CHEMBL503871 | C41H45NO18 | 839.8 g/mol | CC(=O)OCC12C(C(C3C(C14C(C(C(=O)C2OC(=O)C)C(O4)(COC(=O)C5=C(CCC(C(=O)O3)(C)O)N=CC=C5)C)OC(=O)C)(C)O)OC(=O)C6=CC=CC=C6)OC(=O)C |
| TCMBANKIN007562 | 1-(4-hydroxy-3-methoxyphenyl)-3,5-octane-diol | 1-(4-hydroxy-3-methoxyphenyl)octane-3,5-diol; AC1NSWME | C15H24O4 | CCCC(CC(CCC1=CC(=C(C=C1)O)OC)O)O | |
| TCMBANKIN007717 | 6p- hydroxy- bean-4-en-3-one | ||||
| TCMBANKIN007753 | catechin lactone A | ||||
| TCMBANKIN008011 | quercetin-3,7-dirhamnoside; | ||||
| TCMBANKIN008330 | 5,8,4'-trihydroxy-7-methoxyisoflavone | ||||
| TCMBANKIN008386 | Methyl atratate | Benzoic acid, 2,4-dihydroxy-3,6-dimethyl-, methyl ester; CBDivE_016254; 2,4-dihydroxy-3,6-dimethyl-benzoic acid methyl ester; beta-Resorcyclic acid, 3,6-dimethyl-, methyl ester; beta-Resorcylic acid, 3,6-dimethyl-, methyl ester; MLS000517295; SMR000127412; 136218-95-6; EINECS 225-193-0; 4707-47-5; Methyl-3-methylorsellinate; Methyl beta-orcinolcarboxylate; Evernyl; Atraric acid;; Methyl beta-orcinolcarboxylate; Methyl 3,6-dimethylresorcylate; ZINC00239015; Methyl 2,4-dihydroxy-3,6-dimethylbenzoate; 2,4-dihydroxy-3,6-dimethylbenzoic acid methyl ester; methyl 2,4-dihydroxy-3,6-dimethyl-benzoate; .beta.-Resorcylic acid, 3,6-dimethyl-, methyl ester; ST5408246; AIDS097062; AIDS-097062; W523305_ALDRICH | C10H12O4 | 196.2 | CC1=CC(=C(C(=C1C(=O)OC)O)C)O |
| TCMBANKIN008959 | hibridin | ||||
| TCMBANKIN009190 | lupenone | lupenone ; 1617-70-5; LUPENONE; SCHEMBL1483620; NSC 281807; ZINC04081760; Lup-20(29)-en-3-one (8CI)(9CI); (1R,3aR,4S,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-1-Isopropenyl-3a,5a,5b,8,8,11a-hexamethyl-eicosahydro-cyclopenta[a]chrysen-9-one; AIDS-082905; AIDS082905 | C30H48O | 424.7 g/mol | CC(=C)C1CCC2(C1C3CCC4C5(CCC(=O)C(C5CCC4(C3(CC2)C)C)(C)C)C)C |
| TCMBANKIN009333 | 1,8-dihydroxy-4-hydroxymethyl anthraquinone | C15H10O5 | 270.24 g/mol | C1=CC2=C(C(=C1)O)C(=O)C3=C(C=CC(=C3C2=O)CO)O | |
| TCMBANKIN009423 | ciwujiatone | C22H26O9 | 434.44 | COC1=CC(=CC(=C1O)OC)C2C(C(CO2)C(=O)C3=CC(=C(C(=C3)OC)O)OC)CO | |
| TCMBANKIN009952 | enaminousnic acid | ||||
| TCMBANKIN010250 | diapinoresinol mono methy erther | ||||
| TCMBANKIN010270 | kaemperfnl-7-o-L-rharnnoside | ||||
| TCMBANKIN011008 | 1,6-dihydroxy-3,5,7-trimethoxyxanthone | MolPort-039-338-634; CTK1I3696; 65008-17-5; AKOS030562641; 1,6-DIHYDROXY-3,5,7-TRIMETHOXY-9H-XANTHEN-9-ONE; AC1NSURM; 9H-Xanthen-9-one, 1,6-dihydroxy-3,5,7-trimethoxy-; ZINC14649050; 1,6-Dihydroxy-3,5,7-trimethoxyxanthone; DTXSID40415710; AK594542; 3,8-dihydroxy-2,4,6-trimethoxyxanthone; 1,6-dihydroxy-3,5,7-trimethoxyxanthen-9-one | C16H14O7 | 318.28 g/mol | COC1=CC(=C2C(=C1)OC3=C(C(=C(C=C3C2=O)OC)O)OC)O |
| TCMBANKIN012479 | fridelin | ||||
| TCMBANKIN012581 | kaemperfnl-7-dirhamnoside | ||||
| TCMBANKIN012867 | 11- acetyl carbonyl-p- frankincense acid | ||||
| TCMBANKIN013025 | 6β-hydroxy-stigmasta-4-en-3-one | ||||
| TCMBANKIN013598 | Paniculatin | SCHEMBL4742129; paniculatin; LMPK12050162 | C27H30O15 | 594.5 g/mol | C1=CC(=CC=C1C2=COC3=C(C(=C(C(=C3C2=O)O)C4C(C(C(C(O4)CO)O)O)O)O)C5C(C(C(C(O5)CO)O)O)O)O |
| TCMBANKIN014618 | Campesteryl ferulate | campesteryl ferulate | C38H56O4 | 576.85 | CC(C)C(C)CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC(=O)C=CC5=CC(=C(C=C5)O)OC)C)C |
| TCMBANKIN014903 | 5,8,2'-Trihydroxy-7-methoxyflavone | 5,8-dihydroxy-2-(2-hydroxyphenyl)-7-methoxy-4-chromenone; 5,8-dihydroxy-2-(2-hydroxyphenyl)-7-methoxy-chromen-4-one; LMPK12111302; AC1L4H6K; 77056-20-3; 5,8,2'-trihydroxy-7-methoxyflavone; 5,8-dihydroxy-2-(2-hydroxyphenyl)-7-methoxychromen-4-one; DTXSID20227853; 4H-1-Benzopyran-4-one, 5,8-dihydroxy-2-(2-hydroxyphenyl)-7-methoxy-; 5,8-dihydroxy-2-(2-hydroxyphenyl)-7-methoxy-chromone | C16H12O6 | 300.26 | COC1=C(C2=C(C(=C1)O)C(=O)C=C(O2)C3=CC=CC=C3O)O |
| TCMBANKIN014948 | Pinoresinol mono methy erther | ||||
| TCMBANKIN015204 | dehydrodicatechin A | C30H24O12 | 576.5 g/mol | C1C(C(OC2=C1C(=CC3=C2C4=CC(=O)C5(CC4(O3)C6C(O5)CC7=C(C=C(C=C7O6)O)O)O)O)C8=CC(=C(C=C8)O)O)O | |
| TCMBANKIN015891 | 5,7,2'-trihydroxy-6-methyl-3-(3',4'-methylene-dioxybenzyl)chromone | C18H14O7 | CC1=C(C=C2C(=C1O)C(=O)C(=CO2)CC3=C(C4=C(C=C3)OCO4)O)O | ||
| TCMBANKIN016632 | 8-methoxy-5-o-glucoside flavone | 8-methoxy-2-phenyl-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one; AC1NSY3A | COC1=C2C(=C(C=C1)OC3C(C(C(C(O3)CO)O)O)O)C(=O)C=C(O2)C4=CC=CC=C4 | ||
| TCMBANKIN016775 | eriodictyol-7,3-diglucoside | 2-(3,4-Dihydroxyphenyl)-3-(beta-D-glucopyranosyloxy)-5-hydroxy-7-(beta-D-glucopyranosyloxy)-2,3-dihydro-4H-1-benzopyran-4-one; AC1NSV7H; 2-(3,4-dihydroxyphenyl)-5-hydroxy-3,7-bis[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]-2,3-dihydrochromen-4-one | C27H32O17 | 628.5 g/mol | C1=CC(=C(C=C1C2C(C(=O)C3=C(C=C(C=C3O2)OC4C(C(C(C(O4)CO)O)O)O)O)OC5C(C(C(C(O5)CO)O)O)O)O)O |
| TCMBANKIN017027 | aleanolie | ||||
| TCMBANKIN018907 | Orcinol carboxylate | ||||
| TCMBANKIN019315 | 5,7,3 ', 4'-tetrahydroxy-6,8-isopentenyl isoflavones | ||||
| TCMBANKIN020140 | 3,5,7,2',6'-pentahydroxy flavanonol | C15H12O7 | COC1=CC(=C2C(=C1)OC3=CC(=C(C(=C3C2=O)O)OC)O)O | ||
| TCMBANKIN020433 | camaldulenic acid | ca-maldulenic acid | C30H46O4 | 470.7 g/mol | CC1(CCC2(CCC3(C(=C2C1)C=CC4C3(CCC5C4(CC(C(C5(C)C)O)O)C)C)C)C(=O)O)C |
| TCMBANKIN020464 | 3alpha-dihydroxyursen-12-en-28-oate | ||||
| TCMBANKIN020531 | 3-O-α-L-rasnnopyranoside | ||||
| TCMBANKIN020832 | Dihydrobaicalin | (2S)-5,6-Dihydroxy-7-(beta-D-glucurono pyranosyloxy)flavanone; dihydrobaicalin; BDBM50250625; CHEMBL467197 | C21H20O11 | 448.4 g/mol | C1C(OC2=CC(=C(C(=C2C1=O)O)O)OC3C(C(C(C(O3)C(=O)O)O)O)O)C4=CC=CC=C4 |
| TCMBANKIN021067 | (2S,3R)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)chroman-4-one | (2S,3R)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-4-chromanone | C15H12O6 | 288.25 | |
| TCMBANKIN021120 | 2,7-dihydroxy-4-methoxy- | 402.43 | |||
| TCMBANKIN022064 | 3β-hydroxy-30-norlupan-20-one | ||||
| TCMBANKIN022090 | oxalaceticacid | C4H4O5 | 132.07 g/mol | C(C(=O)C(=O)O)C(=O)O | |
| TCMBANKIN022128 | 6-methoxy group-7-hydroxy Coumarin | ||||
| TCMBANKIN022219 | eupachlorin | C20H25ClO7 | 412.9 g/mol | CC=C(C)C(=O)OC1CC(C2C(C=C(C2(C3C1C(=C)C(=O)O3)O)C)O)(CCl)O | |
| TCMBANKIN022529 | isoscutellarein | DTXSID20415172; 5,7,8-trihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one; CTK4I4833; 5,7,8-trihydroxy-2-(4-hydroxyphenyl)chromen-4-one; SCHEMBL476215; Isoscutellarein; 8-Hydroxyapigenin; 41440-05-5; AC1NQYUJ; CHEBI:6059; LMPK12111361; CHEMBL1093284; 4',5,7,8-Tetrahydroxyflavone; C10097 | C15H10O6 | 286.24 g/mol | C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C(=C(C=C3O)O)O)O |
| TCMBANKIN022801 | 3,4',5-Trihydroxy-7-methoxy-8-isopente-nylflavone | 3,5-dihydroxy-2-(4-hydroxyphenyl)-7-methoxy-8-(3-methylbut-2-enyl)chromen-4-one; 3,5-dihydroxy-2-(4-hydroxyphenyl)-7-methoxy-8-(3-methylbut-2-enyl)chromone; 3,5-dihydroxy-2-(4-hydroxyphenyl)-7-methoxy-8-(3-methylbut-2-enyl)-4-chromenone | C21H20O6 | 368.38 | |
| TCMBANKIN024686 | Kaempferol 3,7-rhamnose | ||||
| TCMBANKIN024860 | ZINC04073977 | (8S,9S,10R,13R,14S,17R)-17-[(1R,4R)-4-ethyl-1,5-dimethylhexyl]-10,13-dimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; (8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methyl-heptan-2-yl]-10,13-dimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; (8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; (8S,9S,10R,13R,14S,17R)-17-[(1R,4R)-4-ethyl-1,5-dimethyl-hexyl]-10,13-dimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one | C29H48O | 412.69 | |
| TCMBANKIN024986 | phenylbutanone-glucoside | CC(=O)CCC1=CC=C(C=C1)OC2C(C(C(C(O2)CO)O)O)O | |||
| TCMBANKIN025575 | acovnosigenin A | ||||
| TCMBANKIN026089 | euonyrnusoside A | C41H64O19 | CC1C(C(C(C(O1)OC2CC3CCC4C(C3(C(C2)O)C)CCC5(C4(CCC5C6=CC(=O)OC6)O)C)O)O)OC7C(C(C(C(O7)COC8C(C(C(C(O8)CO)O)O)O)O)O)O | ||
| TCMBANKIN027992 | eriodictyol | Eriodictyol; (2S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-chromanone; 552-58-9; CHEBI:28412; (2S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-2,3-dihydro-4H-chromen-4-one; C05631; (S)-3',4',5,7-Tetrahydroxyflavanone; 74565_FLUKA; eriodictyol ; ERD; (2S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxychroman-4-one; ZINC00058117; (2S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chroman-4-one | C15H12O6 | 288.25 | C1C(OC2=CC(=CC(=C2C1=O)O)O)C3=CC(=C(C=C3)O)O |
| TCMBANKIN028421 | 5,7-dihydroxy-6,8-dime thyl-3-(4'-hydroxy-3'-methoxybenzyl)chroman-4-one | C19H20O6 | 344.4 g/mol | CC1=C(C(=C2C(=C1O)C(=O)C(CO2)CC3=CC(=C(C=C3)O)OC)C)O | |
| TCMBANKIN028660 | suffruticoside a | Suffruticoside A | C27H32O16 | 612.5 g/mol | CC(=O)C1=C(C=C(C=C1)OC)OC2C(C(C(C(O2)COC3C(C(CO3)(COC(=O)C4=CC(=C(C(=C4)O)O)O)O)O)O)O)O |
| TCMBANKIN029094 | 5,7,2'-trihydroxyflavone2'-o-β-d-glucopyranoside | C21H20O10 | |||
| TCMBANKIN029325 | Wilfordside | wilfordside | 883.93 | CC1C2=C(C=NC=C2)C(=O)OCC3(C4C(C(C5(C(C(C(C(C5(C4OC(=O)C)O3)(C)O)OC(=O)C1(C)O)OC(=O)C6=CC=CC=C6)OC(=O)C)COC(=O)C)OC(=O)C)OC(=O)C)C | |
| TCMBANKIN030797 | Dunnisinin | dunnisinin | C11H14O5 | 226.23 g/mol | COC(=O)C1COC2C3C1C=CC3(CO2)O |
| TCMBANKIN030900 | 2,6,2',4'-tetrahydroxy-6'-methoxychaleone | 302.3 | |||
| TCMBANKIN031788 | symplocoside | C22H26O11 | 466.4 g/mol | COC1=C(C=CC(=C1)C2C(CC3=C(C=C(C=C3O2)OC4C(C(C(C(O4)CO)O)O)O)O)O)O | |
| TCMBANKIN031831 | euonymoside a | C35H54O14 | 698.8 g/mol | CC1C(C(C(C(O1)OC2CC3CCC4C(C3(C(C2)O)C)CCC5(C4(CCC5C6=CC(=O)OC6)O)C)OC7C(C(C(C(O7)CO)O)O)O)O)O | |
| TCMBANKIN032110 | 8-(2-pyrrolidinone-5-yl)-catechin | ||||
| TCMBANKIN032222 | woodorien | A-d-glucopyranosyloxy)-4-hydroxybenzoate; Woodorien; 155112-92-8; Benzoic acid, 3-(beta-D-glucopyranosyloxy)-4-hydroxy-, methyl ester; AC1L4URU; AC1Q5ZJK; methyl 3-(; Methyl 3-(beta-D-glucopyranosyloxy)-4-hydroxybenzoate; METHYL 4-HYDROXY-3-{[(2S,3R,4S,5S,6R)-3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)OXAN-2-YL]OXY}BENZOATE; methyl 4-hydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybenzoate | C14H18O9 | 330.29 g/mol | COC(=O)C1=CC(=C(C=C1)O)OC2C(C(C(C(O2)CO)O)O)O |
| TCMBANKIN032347 | 4,5,6-trihydroxy-aurone | SCHEMBL13090724; AC1NT14R; 4, 5, 6-trihydroxy-aurone; (2Z)-2-benzylidene-4,5,6-trihydroxy-1-benzofuran-3-one | C15H10O5 | 270.24 g/mol | C1=CC=C(C=C1)C=C2C(=O)C3=C(O2)C=C(C(=C3O)O)O |
| TCMBANKIN033293 | 4-hydroxyxanthone | C13H8O3 | 212.2 g/mol | C1=CC=C2C(=C1)C(=O)C3=C(O2)C(=CC=C3)O | |
| TCMBANKIN033532 | 5-hydroxy-6-isobutyryl-8-methyl-8-(4-methyl-pent-3-enyl)-4-phenyl-2h-pyrano[2,3-h ]chro-men-2-one | C29H30O5 | |||
| TCMBANKIN033790 | p-hydroxybexizoic acid | ||||
| TCMBANKIN036312 | 20-Hexadecanoylingenol | 20-hexadecanoylingenol | C36H58O6 | 586.94 | CCCCCCCCCCCCCCCC(=O)OCC1=CC2C3C(C3(C)C)CC(C4(C2=O)C=C(C(C4(C1O)O)O)C)C |
| TCMBANKIN036816 | baicalin | 21967-41-9; STOCK1N-21299; (2S,3S,4S,5R,6S)-6-(5,6-dihydroxy-4-oxo-2-phenyl-chromen-7-yl)oxy-3,4,5-trihydroxy-oxane-2-carboxylic acid; (2S,3S,4S,5R,6S)-6-(5,6-dihydroxy-4-oxo-2-phenylchromen-7-yl)oxy-3,4,5-trihydroxyoxane-2-carboxylic acid; 5,6,7-Trihydroxyflavone-7-O-.beta.-D-glucopyranosideuronic acid; C10025; Baicalin; AIDS001402; 100647-26-5; 7-D-Glucuronic acid-5,6-dihydroxyflavone; 5,6-dihydroxy-4-oxo-2-phenyl-4H-chromen-7-yl beta-D-glucopyranosiduronic acid; 31564-28-0; (2S,3S,4S,5R,6S)-6-(5,6-dihydroxy-4-keto-2-phenyl-chromen-7-yl)oxy-3,4,5-trihydroxy-tetrahydropyran-2-carboxylic acid; Baicalein-7-D-glucuronide; TJN-151; CHEBI:2981; (2S,3S,4S,5R,6S)-6-(5,6-dihydroxy-4-oxo-2-phenyl-chromen-7-yl)oxy-3,4,5-trihydroxy-tetrahydropyran-2-carboxylic acid; beta-D-Glucopyranosiduronic acid, 5,6-dihydroxy-4-oxo-2-phenyl-4H-1-benzopyran-7-yl; LMPK12111081; baicalin ; 5,6-dihydroxy-4-oxo-2-phenyl-4H-1-benzopyran-7-yl beta-D-glucopyranosiduronic acid; Baicalein 7-O-glucuronide; 27462-75-5; Baicalein 7-glucuronide; AIDS-001402; (2S,3S,4S,5R,6S)-6-[(5,6-dihydroxy-4-oxo-2-phenyl-7-chromenyl)oxy]-3,4,5-trihydroxy-2-tetrahydropyrancarboxylic acid; 572667_ALDRICH | C21H18O11 | 446.36 | C1=CC=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)OC4C(C(C(C(O4)C(=O)O)O)O)O)O)O |
| TCMBANKIN036834 | wogonoside | wogoninoglucuronide; N2501; wogonoside ; (2S,3S,4S,5R)-2,3,4,5-tetrahydroxy-5-(5-hydroxy-8-methoxy-4-oxo-2-phenylchromen-7-yl)-6-oxohexanoic acid; AC-20339; ZINC21992923; Y0212; BG01748878; AKOS015965557 | C22H20O12 | 476.387 | [C@]1([H])(O[H])[C@@]([H])(C(=O)O[H])O[C@@]([H])(Oc2c(OC([H])([H])[H])c(OC(c3c([H])c([H])c([H])c([H])c3[H])=C([H])C4=O)c4c(O[H])c2O[H])[C@]([H])(O[H])[C@@]1([H])O[H] |
| TCMBANKIN036835 | wogonin | CTK5B8471; AIDS-001403; CCG-208499; ZB015158; 5,7-dihydroxy-8-methoxyflavone; ZINC899093; 5,7-dihydroxy-8-methoxy-2-phenyl-chromone; BG01576594; AN-46964; 632-85-9; V1530; MCULE-9854289767; 5,7-dihydroxy-8-methoxy-2-phenyl-4-chromenone; Vogonin; AIDS001403; NSC717845; SC-25044; 10-29-7; AC1NQYXJ; 5,7-Dihydroxy-8-methoxy-2-phenyl-chromen-4-one(Wogonin); NCGC00247464-01; IN1943; ZINC111327191; BN0711; 4H-1-Benzopyran-4-one,5,7-dihydroxy-8-methoxy-2-phenyl-; s4743; SR-05000002216-2; Norwogonin 8-methyl ether; 5,7-dihydroxy-8-methoxy-2-phenyl-4H-chromen-4-one; 5,7-dihydroxy-8-methoxy-2-phenylchromen-4-one; HY-N0400; BDBM50140257; MFCD12828871; ST077088; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-8-methoxy-2-phenyl-; DTXSID70212557; 5,7-dihydroxy-8-methoxy-2-phenyl-chromen-4-one; 632W859; MFCD00017736; CHEBI:10043; 5,7-dihydroxy-8-methoxy-2-phenyl-4H-1-benzopyran-4-one; BRN 0287152; Wogonin; N1283; SCHEMBL139083; LMPK12111330; I14-8669; NCI60_040649; HMS2270G08; FT-0603499; wagonin; 5-18-04-00571 (Beilstein Handbook Reference); Q-100730; MolPort-001-742-489; SMR001397111; POK93PO28W; AC-20338; MLS002473006; SR-05000002216; CS-3959; CHEMBL16171; D00MXS; 4CN-1056; wogonin ; AKOS015917860; UNII-POK93PO28W; TR-021802; NSC-717845; C-17890; LS-68974; 5,7-Dihydroxy-8-methoxy-2-phenyl-chromen-4-one; FLAVONE, 5,7-DIHYDROXY-8-METHOXY-; XLTFNNCXVBYBSX-UHFFFAOYSA-N; C10197; GP7400; 5,7-Dihydroxy-8-methoxyflavone | C16H12O5 | 284.26 | COC1=C(C=C(C2=C1OC(=CC2=O)C3=CC=CC=C3)O)O |
| TCMBANKIN036840 | protocatechuic acid | 3,4-Dihydroxybenzoic acid; MLS000737807; c0120; 4-Carboxy-1,2-dihydroxybenzene; InChI=1/C7H6O4/c8-5-2-1-4(7(10)11)3-6(5)9/h1-3,8-9H,(H,10,11; NSC 16631; ZB000710; Benzoic acid, 3,4-dihydroxy-; 4,5-dihydroxybenzoate; 3,4-dihydrobenzoic acid; DHB; DB03946; AC1N59J2; CCRIS 6291; AIDS082396; Protocatehuic acid; BRN 1448841; protocatechuicacid; 3,4-dihydroxybenzoate; SMR000528167; D-3487; EINECS 202-760-0; 4,5-Dihydroxybenzoic acid; C00230; Catechol-4-carboxylic Acid; 3,4-DHBA; Protocatechuic acid polymer; CHEBI:36241; 2buv; 4-10-00-01459 (Beilstein Handbook Reference); AIDS-082396; 99-50-3; A846038; AIDS002961; Oxidative polymer of protocatechuic acid; 37580_FLUKA; AIDS-002961; 1ykp; Benzoic acid, 3,4-dihydroxy- (9CI); NSC16631; 3,4-bis(oxidanyl)benzoate; CHEBI:36062; 3, 4-Dihydroxybenzoic acid; TULIP017459 | C18H14O8 | 358.299 | c12c(O[C@]([H])(c3c([H])c([H])c(O[H])c(O[H])c3[H])[C@@]1([H])C(=O)O[H])c(O[H])c([H])c([H])c2\C([H])=C([H])\C(O[H])=O |
| TCMBANKIN036863 | hesperidin | Hesperetin 7-O-rutinoside; Flavanone, 3',5,7-trihydroxy-4'-methoxy-, 7-(6-O-alpha-L-rhamnosyl-delta-glucoside) (7CI); (2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-2-tetrahydropyranyl]oxymethyl]-2-tetrahydropyranyl]oxy]-4-chromanone; 15512-51-3; Hesperitin-7-rhamnoglucoside; (2S)-5-hydroxy-2-(3-hydroxy-4-methoxy-phenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-oxan-2-yl]oxymethyl]oxan-2-yl]oxy-chroman-4-one; Hesperetin-rutinosid; 5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-((6-O-alpha-L-rhamnopyranosyl-beta-D-glucopyranosyl)oxy)-4-chromanon; 520-26-3; CHEBI:28775; (S)-7-[[6-O-(6-Deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one; (2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychroman-4-one; 5-18-05-00218 (Beilstein Handbook Reference); hesperidin ; BSPBio_000619; Hesperidin; BRN 0075140; Atripliside B; 7-((6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one, (S)-; D01038; BCBcMAP01_000136; 3',5'-Dihydroxy-4'-methoxy-7-rutinosyloxyflavan-4-on; 7-(6-O-Desoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyloxy)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-chromanon; (2S)-5-hydroxy-2-(3-hydroxy-4-methoxy-phenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-chroman-4-one; CCRIS 3940; Flavanone, 3',5,7-trihydroxy-4'-methoxy-, 7-(6-O-a-L-rhamnosyl-D-glucoside) (7CI); Glucopyranoside, hesperetin-7 6-O-(6-deoxy-alpha-L-mannopyranosyl)-, beta-D-; NSC 44184; (S)-(--)-hesperidin; (2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside; Prestwick3_000400; 106904-63-6; 28283-75-2; Hesperidine; C09755; AIDS-001414; 16643-24-6; SMP1_000149; Ciratin; Hesperetin, 7-(6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside); Hesperidin (JAN); 17654-22-7; 32737-61-4; 4H-1-Benzopyran-4-one, 7-((6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2,3-dihydo-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (S)-; Hesperetin-rutinoside; EINECS 208-288-1; STOCK1N-12322; AIDS001414; BPBio1_000681; 30927-97-0; Hesper bitabs; 4H-1-Benzopyran-4-one, 7-((6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (2S)-; (2S)-Hesperidin | C28H34O15 | 611 | C([H])([H])([H])[C@]1([H])O[C@@]([H])(OC([H])([H])[C@]2([H])O[C@]([H])(Oc3c([H])c(O[C@@]([H])(c4c([H])c([H])c(OC([H])([H])[H])c(O[H])c4[H])C([H])([H])C5=O)c5c(O[H])c3[H])[C@@]([H])(O[H])[C@]([H])(O[H] )[C@@]2([H])O[H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]1([H])O[H] |
| TCMBANKIN036894 | scutellarin | (2S,3S,4S,5R,6S)-6-[[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-7-chromenyl]oxy]-3,4,5-trihydroxy-2-tetrahydropyrancarboxylic acid; CHEBI:61284; 676536-34-8; 1329-06-2; 4H-1-Benzopyran-4-one, 7-(.beta.-D-glucopyranuronosyloxy)-5,6-dihydroxy-2-(4-hydroxyphenyl)-; Flavone, 4',5,6,7-tetrahydroxy-, 7-beta-D-glucopyranuronoside; scutellarin(1-); scutellarein 7-O-beta-D-glucuronate; Scutellarein-7beta-D-glucuronide; AIDS-314104; AIDS314104; 32647-60-2; Scutellarein-7-O-beta-D-glucuronide; Scutellarein-7-glucuronide; Breviscapine; (2S,3S,4S,5R,6S)-6-[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid; 116122-36-2; Breviscapin; MEGxp0_000554; beta-D-Glucopyranosiduronic acid, 5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-7-yl; Glucopyranosiduronic acid, 5,6-dihydroxy-2-(p-hydroxyphenyl)-4-oxo-4H-1-benzopyran-7-yl, beta-D-; Scutellarin; Scutellarein-7beta-D-glucuronoside; 27740-01-8; 5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-yl beta-D-glucopyranosiduronate; (2S,3S,4S,5R,6S)-6-[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-chromen-7-yl]oxy-3,4,5-trihydroxy-tetrahydropyran-2-carboxylic acid; (2S,3S,4S,5R,6S)-6-[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-keto-chromen-7-yl]oxy-3,4,5-trihydroxy-tetrahydropyran-2-carboxylic acid; (2S,3S,4S,5R,6S)-6-[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-chromen-7-yl]oxy-3,4,5-trihydroxy-oxane-2-carboxylic acid | C21H18O12 | 462.4 g/mol | C1=CC(=CC=C1C2=CC(=O)C3=C(C(=C(C=C3O2)OC4C(C(C(C(O4)C(=O)O)O)O)O)O)O)O |
| TCMBANKIN036913 | naringenin | (2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one; ZINC1785; Spectrum2_000325; 2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; (-)-Naringenin; SDCCGMLS-0066570.P001; (2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one; MLS000574861; KBio2_000727; CHEBI:50201; HMS3468H18; ALBB-015405; NCGC00017346-01; BBL010488; AJ-08090; DivK1c_000118; BB 0261506; (S)-2,3-dihydo-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; CAS-480-41-1; KBio3_001454; SC-85987; 4H-1-benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-, (2R)-; AIDS-001417; NINDS_000118; SCHEMBL17166263; Spectrum3_000567; 2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-benzopyrone; (2R)-naringenin; (2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-chromanone; BSPBio_001954; BB_NC-1001; MCULE-5852778653; NCGC00163598-01; BG01564988; MFCD03265520; naringenin ; 4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-, (2S)-; (2R)-5,7,4'-trihydroxyflavone; AKOS004119880; CHEBI:17846; ST24036200; AC1LDI7C; KBioGR_000508; ZINC00156701; Phytochemistry 8: 127 (1969); R6691; Asahina; 4',5, 7-Trihydroxyflavanone; N1370; (2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4H-chromen-4-one; C00509; 480-41-1; KBio2_003295; (2R)-4',5,7-trihydroxyflavanone; (+)-naringenin; Spectrum_000247; ZB000410; NAR; pelargidanon 1602; (R)-naringenin; IDI1_000118; STK801623; Spectrum5_001423; MolPort-002-507-277; Spectrum4_000124; 17654-19-2; KBio1_000118; KBioSS_000727; (+)-(2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one; (2R)-4',5,7-trihydroxyflavan-4-one; NCGC00016457-01; STOCK1N-05989; KBio2_005863; 5,7-Dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4H-chromen-4-one; AIDS001417; BG00617674; TNP00287; (2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4H-chromen-4-one; SPECTRUM1500746; YSO1; SMR000156272; 4',5,7-triOH-Flavone; SPBio_000329 | C15H12O5 | 272.253 | c1(O[H])c([H])c([H])c([C@]2([H])Oc(c([H])c(O[H])c([H])c3O[H])c3C(=O)C2([H])[H])c([H])c1[H] |
| TCMBANKIN037277 | Oleanolic acid | Olean-12-en-28-oic acid, 3.beta.-hydroxy-; s2334; Caryophyllin; AIDS014809; Giganteumgenin C; SMR000445561; oleanolicacid; (3-beta)-3-Hydroxyolean-12-en-28-oic acid; AIDS-014809; Olean-12-en-28-oic acid, 3-hydroxy-, (3-beta)-; EINECS 208-081-6; NSC 114945; OLEANOLIC ACID; Olean-12-en-28-oic acid, 3-hydroxy-, (3beta)-; CCRIS 6493; AS-11663; SCHEMBL1699365; Virgaureagenin B; CHEBI:37659; MLS000697656; (4aS,5S,6aS,6bR,8R,8aR,10S,12aR,12bR,14bS)-10-Hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydro-2H-picene-4a-carboxylic acid; AKOS022168208; O5504_SIGMA; MolPort-016-633-333; Oleanolic Acid; Olean-12-en-28-oic acid, 3-beta-hydroxy- (8CI); Oleanic acid; 3beta-Hydroxyolean-12-en-28-oic acid; 3-beta-Hydroxyolean-12-en-28-oic acid; ST057162; Olean-12-en-28-oic acid, 3beta-hydroxy- (8CI); NSC114945; Oleanolic Acid (Caryophyllin); Astrantiagenin C; Olean-12-en-28-oic acid, 3-hydroxy-, (3.beta.)-; 508-02-1; (4R,6aS,6bR,8aR,10S,12aR,12bR,14bR)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-3,4,4a,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1H-picene-4-carboxylic acid; (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid; oleanolic acid | C30H48O3 | 457 | C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])=C([C@@]([H])(C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C2([H])[H])[C@@]2(C(=O)O[H])C([H])([H])C3([H])[H])[C@@]34C( [H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C5([H])[H])[C@@]5([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[H] |
| TCMBANKIN037352 | Isoschaftoside | Apigenin 6-C-alpha-L-arabinopyranoside-8-C-beta-D-glucopyranoside; 5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]-6-[(2S,3R,4S,5S)-3,4,5-trihydroxytetrahydropyran-2-yl]chromone; 4H-1-Benzopyran-4-one, 6-alpha-L-arabinopyranosyl-8-beta-D-glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-; 52012-29-0; 5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-6-[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]chromen-4-one; LMPK12110243; 5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]-6-[(2S,3R,4S,5S)-3,4,5-trihydroxytetrahydropyran-2-yl]chromen-4-one; 5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]-6-[(2S,3R,4S,5S)-3,4,5-trihydroxy-2-tetrahydropyranyl]-4-chromenone; 5,7,4'-Trihydroxy-6-C-arabinoside-8-C-glucoside flavone; Isoschaftoside | 564.49 | ||
| TCMBANKIN038168 | wilfordine | C43H49NO19 | 884 | [C@@]1([H])(OC(C([H])([H])[H])=O)[C@@]([H])(OC(C([H])([H])[H])=O)[C@@]2(C([H])([H])OC(C([H])([H])[H])=O)[C@@](O[C@@]3(C([H])([H])[H])C([H])([H])OC(c4c(nc([H])c([H])c4[H])C([H])([H])C([H])([H])[C@@](O[ H])(C([H])([H])[H])C(=O)O5)=O)([C@](O[H])(C([H])([H])[H])[C@]5([H])[C@]([H])(OC(=O)c(c([H])c([H])c6[H])c([H])c6[H])[C@]2([H])OC(C([H])([H])[H])=O)[C@]([H])(OC(C([H])([H])[H])=O)[C@@]13[H] | |
| TCMBANKIN041402 | chlorogenic acid | 3-methyl-1,4,5-tris(oxidanyl)cyclohexane-1-carboxylic acid; 4-prop-1-enylbenzene-1,2-diol; A821421; 4-prop-1-enylbenzene-1,2-diol; 1,3,4-trihydroxy-5-methyl-1-cyclohexanecarboxylic acid; chlorogenic acid ; Chlorogenic acid; chlorogenicacid | C16H18O9 | 354.309 | C1([H])([H])[C@](C(O[H])=O)(O[H])C([H])([H])[C@@]([H])(OC(=O)\C([H])=C([H])/c2c([H])c([H])c(O[H])c(O[H])c2[H])[C@]([H])(O[H])[C@@]1([H])O[H] |
| TCMBANKIN041607 | alpha-phenylcinnamic acid nitrile | α-phenylcinnamicacidnitrile | 205.255 | C1=CC=C(C=C1)C(=CC#N)C2=CC=CC=C2 | |
| TCMBANKIN041611 | evonine | C36H43NO17 | 761.7 g/mol | CC1C(C(=O)OC2C(C(C3(C(C(=O)C4C(C3(C2(C)O)OC4(COC(=O)C5=C1N=CC=C5)C)OC(=O)C)OC(=O)C)COC(=O)C)OC(=O)C)OC(=O)C)C | |
| TCMBANKIN043265 | beta-Skytanthine | beta-Skytanthine; CHEBI:10445; 24282-31-3; DTXSID90331875; C09987; AC1L9D2E; (4S,4aR,7S,7aS)-2,4,7-trimethyl-1,3,4,4a,5,6,7,7a-octahydrocyclopenta[c]pyridine | 167.29 g/mol | ||
| TCMBANKIN043850 | Isoscutellarein 8-O-beta-D-glucuronide | C21H18O18S2 | 622.487 | c1([H])c(O[H])c([H])c([H])c(C2=C([H])C(=O)c(c(O[H])c([H])c(O[H])c3O[C@@]4([H])[C@@]([H])(OS(=O)(O)=O)[C@]([H])(O[H])[C@@](OS(O)(=O)=O)([H])[C@]([H])(C(O[H])=O)O4)c3O2)c1[H] | |
| TCMBANKIN044013 | viscidulin iii-6'-o-β-d-glucopyranoside | ||||
| TCMBANKIN044814 | Oroxylin A 7-O-glucuronide | 460.4 g/mol | |||
| TCMBANKIN046785 | 8-C-Arabinopyranosyl-6-C-glucopyranosyl-5,7-dihydroxyflavone | ||||
| TCMBANKIN047268 | 6-c-arabinosyl-8-c-glucosyl apigenin | C26H28O14 | |||
| TCMBANKIN047869 | 3,5,7,3',4'-pentamethoxyflavone | C20H20O7 | 372.4 g/mol | COC1=C(C=C(C=C1)C2=C(C(=O)C3=C(O2)C=C(C=C3OC)OC)OC)OC | |
| TCMBANKIN048368 | Nothosmyrnol | Benzene, 1-(E)-(1-propenyl)-2,4-dimethoxy; 1-(1-Propenyl)-2,4-dimethoxybenzene; 829-39-0; AC1NSQI7; 2,4-dimethoxy-1-prop-1-enylbenzene; 1-(2,5-dimethoxy)phenyl-1-propene; 2,4-dimethoxy-1-[(E)-prop-1-enyl]benzene; 2,4-Dimethoxy-1-(1-propenyl)benzene; Benzene, 2,4-dimethoxy-1-(1-propenyl)-; SCHEMBL12090696; ghl.PD_Mitscher_leg0.56; SKWTXGMULLCOGN-SNAWJCMRSA-N | C11H14O2 | 178.228 | c1(OC([H])([H])[H])c([H])c(OC([H])([H])[H])c(\C(=C([H])\C([H])([H])[H])[H])c([H])c1[H] |
| TCMBANKIN048875 | 2-(3-Hydroxy-4-methoxyphenyl)-ethyl-1-O-α-L-rhamnosyl-(1→3)-β-D-(4-feruloyl)-glucoside | ||||
| TCMBANKIN056613 | 7-O-Methyl leucopelargonidin-3-mono-glucofuranoside | usnicacid; usnic acid; (?)-usnicacid | C22H26O11 | 466.435 | c1(OC([H])([H])[H])c([H])c(O[C@@]([H])(c2c([H])c([H])c(O[H])c([H])c2[H])[C@]([H])(O[C@]3([H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@]([H])([C@@]([H])(C([H])([H])O[H])O[H])O3)[C@@]4([H])O[H])c4c(O[H])c1[H] |
| TCMBANKIN057917 | OXL | ethane-1,2-dioic acid; CHEBI:16995; CCRIS 1454; EPA Pesticide Chemical Code 009601; Oxaalzuur; Caswell No. 625; Oxalic acid standard solution; NSC115893 (DILITHIUM); 35295_RIEDEL; AI3-26463; 68487_FLUKA; Oxalic acid (8CI); LMFA01170031; Ethanedioic acid (9CI); 553-91-3 (DILITHIUM); Ethandisaeure; 2847-15-6; Acide oxalique; 38250_RIEDEL; C00209; Ultraplast Activate S 52; ethanedioic acid; NSC 62774; Acide oxalique [French]; NCIOpen2_001042; InChI=1/C2H2O4/c3-1(4)2(5)6/h(H,3,4)(H,5,6; Oxalsaeure [German]; OXD; NCI-C55209; BRN 0385686; Oxalate standard for IC; 04621_FLUKA; Oxalsaeure; HSDB 1100; Acidum oxalicum; NCIOpen2_008831; 34287_RIEDEL; Kyselina stavelova; Acido ossalico; Aktisal; NCIOpen2_001202; AIDS-071020; Acido ossalico [Italian]; WLN: QVVQ; oxalic acid; 319201_ALDRICH; 216451-38-6; 658537_ALDRICH; 4-02-00-01819 (Beilstein Handbook Reference); 38255_RIEDEL; NCIOpen2_001022; EINECS 205-634-3; Kyselina stavelova [Czech]; Oxagel; AIDS071020; NSC62774; NCIOpen2_000770; 194131_ALDRICH; Aquisal; 241172_ALDRICH; 34285_RIEDEL; 35294_RIEDEL; Oxiric acid; 63504-28-9; 144-62-7; 75688_FLUKA; Oxalic acid solution; 97993-78-7; HOOCCOOH; Oxaalzuur [Dutch]; Ethanedionic acid; H2ox;oxalic acid;oxalicacid | C2H2O4 | 90.03 g/mol | C(=O)(C(=O)O)O |
| TCMBANKIN057937 | galactitol | meso-galactitol;18089-21-9; EINECS 210-165-2; CHEBI:16813; D0256_SIGMA; NSC 1944; ZINC04521466; (2R,3S,4R,5S)-hexane-1,2,3,4,5,6-hexol; 40742-76-5; ZINC02034453; AI3-19423;C01507; C-25615; Sorbo; I0725; I14-60913; KB-53227; CTK8B4049; L-Iditol, >=98%; FBPFZTCFMRRESA-UNTFVMJOSA-N; AC1NUSPZ; DB-051581; 488-45-9; ANW-43765; CHEBI:18202; MolPort-003-848-134; L-Iditol; CC-29952; AKOS024258141; FT-0627851; K-9194; KS-00000XZK; WURCS=1.0/1,0/[h2121h]; SCHEMBL435775; ZINC5178945; W-202860; (2S,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol; L-Idit; MFCD00064289;dulcitol | C6H14O6 | 182.17 g/mol | C(C(C(C(C(CO)O)O)O)O)O |
| TCMBANKIN057949 | sucrose | Amerfand; 29253-78-9; Sucrose (TN); alpha-D-Glucopyranoside, beta-D-fructofuranosyl-; saccharose; Sugar, compressible (NF); S0389_SIGMA; D06530; C00089; 1-alpha-D-Glucopyranosyl-2-beta-D-fructofuranoside; Sucrose, purified; 8027-47-2; 30027-72-6; 29764-06-5; 86101-30-6; NSC 406942; D06529; Sucrose [USAN:JAN]; 146187-04-4; ST5308554; Sugar, confectioner's; D(+)-Saccharose; S7903_SIGMA; GLC-(1-2)FRU; alpha-D-glucopyranosyl beta-D-fructofuranoside; FICOLL; 151756-02-4; Sugar spheres (NF); White soft sugar (JP15); Sucraloxum [INN-Latin]; Saccharum; alpha-D-Glc-(1-2)-beta-D-Fru; S9378_SIGMA; 76056-38-7; 47289_SUPELCO; D-Sucrose; Sugar spheres; 87430-66-8; 104242-10-6; (alpha-D-Glucosido)-beta-D-fructofuranoside; Table sugar; Sacharose; (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-2-yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol; NCI-C56597; 47167-52-2; CCRIS 2120; alpha-D-Glucopyranoside, beta-D-fructofuranosyl, homopolymer; D06528; Microse; Cane sugar; Amerfond; 64533-66-0; White soft sugar; beta-D-Fruf-(2<->1)-alpha-D-Glcp; sugar; White sugar; SUC; 84097_FLUKA; Rock candy; beta-D-Fructofuranosyl-alpha-D-glucopyranoside; Fructofuranoside, alpha-D-glucopyranosyl, beta-D; 80165-03-3; 47257-91-0; CHEBI:17992; 47185-09-1; S5390_SIGMA; alpha-D-Glucopyranoside, beta-D-fructofuranosyl; S1888_SIGMA; 220376-22-7; D06533; 8030-20-4; S3929_SIGMA; S1174_SIGMA; 65545-99-5; Glucopyranoside, beta-D-fructofuranosyl, alpha-D; S2395_SIGMA; 78654-77-0; D06531; (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol; SUCROSE; S5016_SIAL; 51909-69-4; 85456-51-5; D()-Saccharose; ZINC04217475; 84100_FLUKA; D00025; Confectioner's sugar; EINECS 200-334-9; Sugar, confectioner's (NF); 57-50-1; 100405-08-1; 92004-84-7; Beet sugar; S5391_SIGMA; Sucrose, dust; alpha-D-Glc-(1->2)-beta-D-Fru; beta-D-Fructofuranosyl alpha-D-glucopyranoside; 131932-12-2; HSDB 500; Sugar, compressible; AI3-09085; alpha-D-Glucopyranosylbeta-D-fructofuranoside; Rohrzucker; 16104_RIEDEL; (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-dimethylol-tetrahydrofuran-2-yl]oxy-6-methylol-tetrahydropyran-3,4,5-triol; Granulated sugar; S8501_SIGMA; Sucrose, purified (JAN); 146054-35-5; Sucrose (JP15/NF); 9012-95-7; Sucrose, pure; 75398-84-4; 50857-68-6; (2R,3R,4S,5S,6R)-2-[[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)-2-tetrahydrofuranyl]oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol; 25702-74-3; D(+)-Sucrose | C12H22O11 | 342.3 g/mol | C(C1C(C(C(C(O1)OC2(C(C(C(O2)CO)O)O)CO)O)O)O)O |
| TCMBANKIN057971 | sebacicacid | AC1MI2Z2; EINECS 256-186-0; ACM45037670; sebacic acid; 45037-67-0; DTXSID50196366; Sebacaldehyde; decanedial; CTK1D8105; SCHEMBL453083; Usaf hc-1; 4-02-00-02078 (Beilstein Handbook Reference); 422088_ALDRICH; 26776-29-4; 4-OXODECANEDIOIC ACID; AI3-09127; S1752_ALDRICH; 4-OXOSEBACIC ACID; n-Decanedioic acid; Decanedicarboxylic acid; Mixture of undecanedioic acid; CHEBI:41865; Decanedioic acid; 4,7-DIOXOSEBACIC ACID; 14047-57-5; NSC19492; 111-20-6; EINECS 203-845-5; Sebacic acid; 32734-00-2; BRN 1210591; WLN: QV8VQ; NCGC00164361-01; Decanedioic acid, homopolymer; AIDS002604; Dodecanedioic acid and sebacic acid; Sebacic acids; 283258_ALDRICH; 1,8-Octanedicarboxylic acid; NSC 19492; C08277; CCRIS 2290; Sebacinsaeure; NCI60_001628; Polysebacic polyanhydride; Sebacinsaure [German]; Acide sebacique [French]; 84809_FLUKA; NCIOpen2_008624; 84810_FLUKA; AIDS-002604; 1,10-Decanedioic acid; LMFA01170006; CORFREE M1; decanedioic acid | C10H18O4 | 202.25 g/mol | C(CCCCC(=O)O)CCCC(=O)O |
| TCMBANKIN058114 | trans-caffeic acid | 3-(3,4-dihydroxy-phenyl)-acrylic acid; caffeic acid; Caffeate; Lopac-C-0625; 71693-97-5; DivK1c_006624; KBio2_007302; (Z)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; NCGC00015206-02; CAS-3331-39-5; 60020_FLUKA; AI3-63211; 3-(3,4-Dihydroxyphenyl)-2-propenoic acid polymer; (E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; NSC623438; 4-(2'-Carboxyvinyl)-1,2-dihydroxybenzene; KBio2_004734; (2Z)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; CHEMBL1320034; AIDS-002287; AIDS002287; 501-16-6; CHEBI:36281; Prestwick1_000902; KBio1_001568; 3-(3,4-Dihydroxyphenyl)-2-propenoic acid; AKOS000273846; OR1165; SMR000058214; Spectrum2_001612; 3,4-dihydroxycinnamate; (Z)-3-(3,4-dihydroxyphenyl)acrylic acid; Caffeicacid; KOP; AC1NO658; CCRIS 847; Caffeic acid dehydrogenation homopolymer; SPECTRUM1503987; Spectrum4_001694; SCHEMBL3682144; NCGC00017364-01; NCGC00022654-08; 4-(2-Carboxyethenyl)-1,2-dihydroxybenzene; 78734C5A-1281-44D4-B8A0-A3188AD437E3; cis-Caffeic acid; 3-(3,4-dihydroxyphenyl)acrylic acid; Cinnamic acid, 3,4-dihydroxy-; KBioGR_001988; 3,4-Dihydroxybenzeneacrylic acid; 3,4-dihydroxycinnamic acid; trans-caffeic acid; AIDS-026339; NCGC00015206-01; HSDB 7088; ZINC4482687; (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; 3-(3,4-dihydroxyphenyl)prop-2-enoate; Isocaffeic acid; SBB006475; InChI=1/C9H8O4/c10-7-3-1-6(5-8(7)11)2-4-9(12)13/h1-5,10-11H,(H,12,13)/b4-2; NCGC00017364-02; EU-0100208; C01197; MolPort-001-759-162; KBioSS_002166; Caffeic acid pure; caffeic acid ; trans-Caffeate; (2E)-3-(3,4-dihydroxyphenyl)acrylic acid; NSC 57197; (2E)-3-(3,4-Dihydroxyphenyl)-2-propenoic acid; Spectrum_001686; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, (E)-; KBio2_002166; Caffeic acid, cis-; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-; 3,4-Dihydroxybenzeneacrylate; 3-(3,4-Dihydroxy phenyl)-2-propenoic acid; 4361-87-9; 3,4-Dihydroxy-trans-cinnamate; caffeicacid; AR-360/40806927; EINECS 206-361-2; 60018_FLUKA; Caffeic acid polymer; (E)-3-(3,4-dihydroxyphenyl)acrylic acid; NCGC00022654-04; ZX-AL002121; C0625_SIGMA; SDCCGMLS-0002982.P003; 3-(3,4-Dihydroxyphenyl)-2-propenoic acid, homopolymer; SPBio_001643; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)- (9CI); NCGC00017364-03; 3-(3,4-dihydroxyphenyl)prop-2-enoic acid; AC1LU7RL; SPBio_002943; CHEBI:16433; AIDS026339; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, homopolymer; CHEBI:17395; TNP00311; SpecPlus_000528; Prestwick0_000902; MLS000069738; 3,4-dihydroxy-cinnamic acid; 3-(3,4-Dihydroxyphenyl)propenoic acid; NCI60_004400; NSC57197; Caffeic; Lopac-C-0625; NCGC00015206-01; Caffeic acid; cis-Caffeic acid; NCGC00017364-01; (Z)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; C01481; 331-39-5; NCGC00015206-02; CAS-3331-39-5; 3,4-Dihydroxycinnamic acid; CHEBI:17395; (2Z)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; TNP00311; (Z)-3-(3,4-dihydroxyphenyl)acrylic acid; Caffeate; 1- coffee acid | C9H8O4 | 180.16 g/mol | C1=CC(=C(C=C1C=CC(=O)O)O)O |
| TCMBANKIN058130 | quercetin-３-Ｏ-galactoside | hyperin; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one; SMR000466394; C10073; ACon1_000623; Quercetin 3-O-beta-D-galactopyranoside; Quercetin-3-O-galactoside;p Hyperin; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-; 482-36-0; Hyperin; Quercetin 3-galactoside; AIDS026341; Hyperasid; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-4-chromenone; NSC 407304; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-chromone; Quercetin-3-O-galactoside; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-chromen-4-one; Hyperozide; AIDS-026341; MLS000759538; Quercetin 3-D-galactoside; EINECS 207-580-6; Quercetin-3-galactoside; Hyperin (8CI); Hyperoside; 2-(3,4-Dihydroxyphenyl)-3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one; 83388_FLUKA; MEGxp0_000392; Hyperosid; Quercetin 3-beta-D-galactopyranoside | C21H19O12- | 463.4 g/mol | C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O)[O-] |
| TCMBANKIN058131 | hyperoside | quercetin-3-O-beta-galactoside; Quercetin-3-O-Galactoside; Quercetin 3-O-galactoside | C21H20O12 | 464.4 g/mol | C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O)O |
| TCMBANKIN058213 | kaemferol;kampferol;kaempferol;campherol | TNP00039; nchembio.2007.28-comp30; Kaempherol; 5-18-05-00251 (Beilstein Handbook Reference); Prestwick2_001098; CHEBI:28499; Prestwick1_001098; CAS-520-18-3; BRN 0304401; Flavone, 3,4',5,7-tetrahydroxy-; ST030560; MEGxp0_001283; 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-5,7,4'-Trihydroxyflavonol; C.I. 75640; Swartziol; K0133_SIGMA; kaempferol oxoanion; NCGC00016480-01; 60010_FLUKA; EINECS 208-287-6; Pelargidenon; Nimbecetin; 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-4-chromenone; NSC 407289; 3,4',5,7-Tetrahydroxyflavone; HSCI1_000027; Pelargidenolon 1497; NSC407289; Robigenin; C05903; CPD1F-90; Kampferol; NSC 656277; Prestwick0_001098; 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromen-4-one; Populnetin; Kampcetin; Prestwick3_001098; AIDS-001404; ZINC00137345; kaempferol ; 5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-olate; 3,4′,5,7-Tetrahydroxyflavone; Rhamnolutein; NCGC00016480-02; ACon1_001867; NSC656277; 3,4′,5,7-Tetrahydroxyflavone; BSPBio_001176; SPBio_003058; Oprea1_650954; 5,7,4'-Trihydroxyflavonol; 4H-1-Benzopyran-4-one,3,5,7-trihydroxy-2-(4-hydroxyphenyl)-5,7,4'-Trihydroxyflavonol; 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)- (9CI); Campherol; 520-18-3; 3,5,7-TRIHYDROXY-2-(4-HYDROXYPHENYL)-4H-CHROMEN-4-ONE; S00111; Trifolitin; Kampherol; AI3-36096; 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromone; Indigo yellow; Pelargidenolon; AIDS001404; nchembio718-comp14; NCGC00091036-01; Flavone, 3,4',5,7-tetrahydroxy- (7CI,8CI); CHEBI:58573; Kaemferol; Kempferol; BPBio1_001294; 3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; Rhamnolutin; 3,5,7-triOH-Flavone; KMP; CCRIS 41; 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)- | C15H10O6 | 286.24 g/mol | C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O |
| TCMBANKIN058220 | breviscapine | 5,6,4'-trihydroxyflavone-7-o-beta-d-galactonic acid;scutellarin;5,6,4'-trihydroxyflavone-7-o-β-d-galactonicacid;(2S,3S,4S,5R,6S)-6-[[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-7-chromenyl]oxy]-3,4,5-trihydroxy-2-tetrahydropyrancarboxylic acid; CHEBI:61284; 676536-34-8; 1329-06-2; 4H-1-Benzopyran-4-one, 7-(.beta.-D-glucopyranuronosyloxy)-5,6-dihydroxy-2-(4-hydroxyphenyl)-; Flavone, 4',5,6,7-tetrahydroxy-, 7-beta-D-glucopyranuronoside; scutellarin(1-); scutellarein 7-O-beta-D-glucuronate; Scutellarein-7beta-D-glucuronide; AIDS-314104; AIDS314104; 32647-60-2; Scutellarein-7-O-beta-D-glucuronide; Scutellarein-7-glucuronide; Breviscapine; (2S,3S,4S,5R,6S)-6-[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid; 116122-36-2; Breviscapin; MEGxp0_000554; beta-D-Glucopyranosiduronic acid, 5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-7-yl; Glucopyranosiduronic acid, 5,6-dihydroxy-2-(p-hydroxyphenyl)-4-oxo-4H-1-benzopyran-7-yl, beta-D-; Scutellarin; Scutellarein-7beta-D-glucuronoside; 27740-01-8; 5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-yl beta-D-glucopyranosiduronate; (2S,3S,4S,5R,6S)-6-[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-chromen-7-yl]oxy-3,4,5-trihydroxy-tetrahydropyran-2-carboxylic acid; (2S,3S,4S,5R,6S)-6-[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-keto-chromen-7-yl]oxy-3,4,5-trihydroxy-tetrahydropyran-2-carboxylic acid; (2S,3S,4S,5R,6S)-6-[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-chromen-7-yl]oxy-3,4,5-trihydroxy-oxane-2-carboxylic acid | C21H18O12 | 462.4 g/mol | C1=CC(=CC=C1C2=CC(=O)C3=C(C(=C(C=C3O2)OC4C(C(C(C(O4)C(=O)O)O)O)O)O)O)O |
| TCMBANKIN058221 | apigenin | 520-36-5; Spectrum2_000428; 10798_FLUKA; Biochem Biophys Res Comm 212: 767 (1997); CCRIS 3789; AIDS001401; apigenin-7-olate; KBioGR_002565; KBio3_002887; BSPBio_000368; 5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one; HSCI1_000221; Flavone, 4',5,7-trihydroxy-; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxyphenyl)-; EINECS 208-292-3; A3145_SIGMA; 7-hydroxy-2-(4-hydroxyphenyl)-4-oxo-1-benzopyran-5-olate; CHEBI:18388; IDI1_000798; NCGC00025057-04; AIDS-001401; NSC 83244; BPBio1_000406; Apigenol; 5,7-dihydroxy-2-(4-hydroxyphenyl)-4-chromenone; NINDS_000798; NCGC00015049-02; 4′,5,7-Trihydroxyflavone; SPBio_002307; Prestwick_719; 2-(4-hydroxyphenyl)-7-oxidanyl-4-oxidanylidene-chromen-5-olate; Spectrum4_001999; Chamomile; KBio1_000798; BRN 0262620; Prestwick2_000414; Prestwick3_000414; SDCCGMLS-0066379.P001; CHEBI:58470; 5,7, 4'-trihydroxyflavone; NCGC00025057-02; 2-(p-Hydroxyphenyl)-5,7-dihydroxychromone; 5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; APIGENIN; Lopac0_000065; K00045; 4′,5,7-Trihydroxyflavone; 5,7-Dihydroxy-2-(4-hydroxyphenyl)-4-benzopyrone; NCGC00025057-09; 5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one; ACon1_002450; Oprea1_622293; EU-0100065; nchembio790-comp26; 4',5,7-Trihydroxyflavone; NCGC00025057-08; ND-9076; NCGC00025057-01; MEGxp0_000176; Apigenin; 4',5,7-Trihydroxyflavone; apigenin ; Prestwick1_000414; NCGC00015049-01; ZINC00004495; NCGC00025057-05; Spectrum3_001882; BiomolKI_000078; NCI60_041830; Bio1_001354; ghl.PD_Mitscher_leg0.1194; SPECTRUM200846; A828903; DivK1c_000798; 5-18-04-00574 (Beilstein Handbook Reference); 5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-olate; C.I. Natural Yellow 1; 461015-54-3; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxyphenyl)- (9CI); 5,7-dihydroxy-2-(4-hydroxyphenyl)chromone; SMP2_000338; BiomolKI2_000082; Prestwick0_000414; Tocris-1227; Lopac-A-3145; Bio1_000865; NSC83244; Versulin; Pelargidenon 1449; Bio1_000376; Spigenin; 5,7,4'-Trihydroxyflavone; ST056301; UCCF 031; SPBio_000416; Apigenine; C01477; CAS-520-36-5; BSPBio_003384 | C15H10O5 | 270.24 | C1=CC(=CC=C1C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O |
| TCMBANKIN058233 | aromadendrol | A827424; dihydrokaempferol; (2R,3R)-3,5-dihydroxy-2-(4-hydroxyphenyl)-4-oxochroman-7-olate; (2R,3R)-3,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dihydro-2H-1-benzopyran-5-olate; (2R,3R)-2-(4-hydroxyphenyl)-3,7-bis(oxidanyl)-4-oxidanylidene-2,3-dihydrochromen-5-olate; (+)-dihydrokaempferol 7-oxoanion; CHEBI:57294 | C15H12O6 | 288.25 g/mol | C1=CC(=CC=C1C2C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O |
| TCMBANKIN058293 | BOX | FEMA No. 2131; Benzenemethanoic acid; Retardex; Caswell No. 081; LS-280; Benzeneformic acid; benzoic acid; 1863-63-4 (AMMONIUM SALT); E 210; 65-85-0; 109479_SIAL; benzenecarboxylic acid; Benzoic acid (TN); NSC7918 (AMMONIUM SALT); AI3-03710; WLN: QVR; BEZ; 582-25-2 (POTASSIUM SALT); Kyselina benzoova; 33047_RIEDEL; C00180; Flowers of benzoin; HSDB 704; W213128_ALDRICH; ST5213864; nchembio.2007.22-comp2; C03096; D00038; B8027_SIGMA; Kyselina benzoova [Czech]; InChI=1/C7H6O2/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H,8,9; EPA Pesticide Chemical Code 009101; Benzoesaeure [German]; Benzoesaeure; 18102_RIEDEL; Benzoic acid [USAN:JAN]; W213101_ALDRICH; 8013-63-6; Dracylic acid; Unisept BZA; AIDS-018010; phenylformic acid; Benzoic acid (JP15/USP); 47849_SUPELCO; Retarder BA; Aromatic hydroxy acid; B2670_SIGMA; CHEBI:30746; B2920_SIGMA; Mettler Toledo Calibration substance ME 18555, Benzoic acid; CCRIS 1893; Benzoesaeure GV; Acido benzoico [Italian]; Benzoic acid (natural); NSC149; Benzoic acid-ring-UL-14C; Benzoesaeure GK; Acide benzoique; Flowers of benjamin; Benzoic acid, tech.; AI3-0310; HA 1 (acid); Salvo liquid; Acide benzoique [French]; 12353_FLUKA; Tenn-Plas; Carboxybenzene; 242381_SIAL; Salvo, liquid; AIDS018010; Phenylcarboxylic acid; NCGC00091886-01; Solvo powder; 427608_ALDRICH; Benzoic acid (7CI,8CI,9CI); 33045_RIEDEL; HA 1; 73983_FLUKA; Solvo, powder; Benzoate (VAN); NSC 149; EINECS 200-618-2;benzenecarboxylic acid | C7H6O2 | 122.12 | C1=CC=C(C=C1)C(=O)O |
| TCMBANKIN058318 | baicalein-7-o-β-d-glucopyranoside | C21H20O10 | C1=CC=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)OC4C(C(C(C(O4)CO)O)O)O)O)O | ||
| TCMBANKIN058319 | chrysin | NCI60_003886; AIDS-001398; NCGC00094842-05; Spectrum5_001503; 5,7-dihydroxy-2-phenyl-chromen-4-one; 5,7-dihydroxy-2-phenyl-4H-chromen-4-one; CAS-480-40-0; AIDS001398; Spectrum3_001399; KBio3_002238; 5,7-dihydroxy-2-phenylchromen-4-one; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-phenyl- (9CI); NCGC00094842-04; 5,7-dihydroxy-2-phenyl-4-chromenone; BPBio1_000746; SPBio_000766; 5-18-04-00076 (Beilstein Handbook Reference); SPBio_002897; SBB012459; KBioSS_000725; SPECTRUM1500709; BSPBio_003018; KBio2_000725; chrysin ; Prestwick2_000889; 5,7-dihydroxyflavone; Spectrum4_000780; FLAVONE, 5,7-DIHYDROXY-; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-phenyl-; Spectrum_000245; Spectrum2_000753; KBio2_003293; 5,7-diOH-Flavone; SDCCGMLS-0066586.P001; KBio1_000614; NCGC00016456-01; SPECTRUM1505144; IDI1_000614; EINECS 207-549-7; Oprea1_045160; SMP1_000070; Prestwick3_000889; Chrysine; KBio2_005861; Prestwick1_000889; 5,7-Dihydroxy-2-phenyl-4H-benzo(b)pyran-4-one; S00112; NCGC00094842-01; NCGC00094842-03; MEGxp0_001416; C80105_ALDRICH; DivK1c_000614; 5,7-dihydroxy-2-phenyl-chromone; KBioGR_001200; NCGC00094842-02; 5,7-Dihydroxyflavone; NINDS_000614; BSPBio_002514; 5,7-Dihydroxy-2-phenyl-4H-1-benzopyran-4-one; ZINC00057650; 480-40-0; ACon1_000087; 27214_FLUKA; C10028; NSC 407436; BRN 0233276; Prestwick0_000889; NSC407436; BSPBio_000678; Chrysin; 5,7-dihydroxyflavone | C15H10O4 | 254.24 g/mol | C1=CC=C(C=C1)C2=CC(=O)C3=C(C=C(C=C3O2)O)O |
| TCMBANKIN058321 | Norwogonin | 70U0WT21IB; AKOS027381297; ST50309217; 5,7,8-trihydroxy-2-phenyl-chromone; 2-Phenyl-5,7,8-trihydroxy-4H-1-benzopyran-4-one; 5,7,8-Trihydroxy-2-phenyl-4H-chromen-4-one; LS-69047; 4H-1-Benzopyran-4-one, 2-phenyl-5,7,8-trihydroxy-; UNII-70U0WT21IB; CHEBI:7642; 4H-1-Benzopyran-4-one, 2-phenyl-5,7,8-trihydroxy- (9CI); ZINC5934539; 4443/9/8; SCHEMBL760431; AC1NQYVA; MCULE-7196250903; 5,7,8-trihydroxy-2-phenylchromen-4-one; LMPK12111329; NSC128304; CTK4I8195; MFCD00016946; 4443-09-8; C-57553; ST5309217; AIDS016591; 5-18-04-00571 (Beilstein Handbook Reference); C10113; NCGC00385188-01!5,7,8-trihydroxy-2-phenylchromen-4-one; 5,7,8-Trihydroxyflavone; DTXSID20196171; norwogonin ; BRN 0272168; FLAVONE, 5,7,8-TRIHYDROXY-; 5,7,8-trihydroxy-2-phenyl-4-chromenone; MolPort-004-960-042; AK394875; CHEMBL485250; 5,7,8-trihydroxy-2-phenyl-chromen-4-one; norwogonin; AIDS-016591; NSC 128304; NSC-128304;nor-wogonin | C15H10O5 | 270.24 g/mol | C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C(=C(C=C3O)O)O |
| TCMBANKIN058322 | baicalein | 5,6,7-trihydroxyflavanone; KBio3_002435; NCGC00025282-03; 5,6,7-trihydroxy-2-phenyl-chromen-4-one; AIDS-000731; 5,6,7-trihydroxy-2-phenyl-4H-chromen-4-one; baicalein ; Sho-saiko-to; 5,6,7-trihydroxy-2-phenylchromen-4-one; ST057152; Spectrum_000427; SPECTRUM1504002; 5,6,7-trihydroxy-2-phenyl-chromone; KBio1_001798; KBio2_006043; NSC 661431; 11712_FLUKA; SDCCGMLS-0066744.P001; KBioSS_000907; CHEBI:2979; SMP1_000037; 5,6,7-trihydroxy-2-phenyl-4-chromenone; LMPK12140610; SPBio_000572; NCGC00025282-02; Dihydrobaicalein; Baicalein; 5,6,7-trihydroxy-2-phenyl-chroman-4-one; Spectrum4_000537; KBioGR_001173; 491-67-8; NCGC00017236-01; S00113; 465119_ALDRICH; Spectrum5_001418; Oprea1_765614; Tocris-1761; DivK1c_006854; NSC729192; AIDS000731; BSPBio_003215; SCHEMBL12068882; 5,6,7-Trihydroxyflavone; Spectrum3_001608; KBio2_003475; SpecPlus_000758; 5,6,7-Trihydroxy-2-phenyl-4H-1-benzopyran-4-one; NSC661431; NCGC00025282-01; 5,6,7-trihydroxy-2-phenyl-3,4-dihydro-2H-1-benzopyran-4-one; C10023; Spectrum2_000466; TNP00121; KBio2_000907; ZINC00017881; Biacalein; 5,6,7-trihy-droxyflavone | C15H10O5 | 270.24 g/mol | C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=C(C(=C3O)O)O |
| TCMBANKIN058414 | 1,8-dihydroxy-4-hydroxymethyl anthraquinone | C15H10O5 | 270.24 g/mol | C1=CC2=C(C(=C1)O)C(=O)C3=C(C=CC(=C3C2=O)CO)O | |
| TCMBANKIN058419 | Xanthone der. | 1,3,5-trihydroxy-9-xanthenone; 1,3,5-Trihydroxyxanthone; 1,3,5-Trihydroxyxanthen-9-one; 6732-85-0; AIDS011160; AIDS-011160; C10094;1,3,5-trihydroxyxanthone | C13H8O5 | 244.2 g/mol | C1=CC2=C(C(=C1)O)OC3=CC(=CC(=C3C2=O)O)O |
| TCMBANKIN058541 | 5,7,4'- Trihydroxyflavanone | (2S)-naringenin | C15H12O5 | 272.25 g/mol | C1C(OC2=CC(=CC(=C2C1=O)O)O)C3=CC=C(C=C3)O |
| TCMBANKIN058698 | trans-shisool | (4-prop-1-en-2-ylcyclohexyl)methanol; AK658944; cis-p-Menth-8-en-7-ol; (Cis-4-(prop-1-en-2-yl)cyclohexyl)methanol; SCHEMBL10886649; Cyclohexanemethanol, 4-(1-methylethenyl)-, trans-; SCHEMBL3129182; CTK0J6379; AKOS030614335; GMYHXOPIKMGWOM-MGCOHNPYSA-N; cis-isopulegone; [4-(prop-1-en-2-yl)cyclohexyl]methanol; 22521-57-9; 4beta-Isopropenylcyclohexane-1beta-methanol; p-Menth-8-en-7-ol; GMYHXOPIKMGWOM-OKXAEBFBSA-N; (4-(prop-1-en-2-yl)cyclohexyl)methanol; CTK0J6334; 18479-64-6; 22451-48-5; SCHEMBL6756040; 4beta-Isopropenylcyclohexane-1alpha-methanol; (4-Isopropenylcyclohexyl)methanol #; trans-Shisool; dihydroperilla-alcohol; SCHEMBL18071864; AC1LATEH; AKOS030614336; Cyclohexanemethanol, 4-(1-methylethenyl)-, cis-; AK658943; GMYHXOPIKMGWOM-AOOOYVTPSA-N; (Trans-4-(prop-1-en-2-yl)cyclohexyl)methanol; Shisool; cis-4-isopropenyl-cyclohexylmethanol; (4-Isopropenylcyclohexyl)methanol; dihydroperilla alcohol | C10H18O | 154.25 g/mol | CC(=C)C1CCC(CC1)CO |
| TCMBANKIN058704 | lupeol | AC-1371; AKOS015960466; SCHEMBL14067725; 4CN-0933; C08628; BC201808; Lup-20(29)-en-3.beta.-ol; NSC90487; ZINC04081455; D0RA6H; Lupeol; LMPR01060013; lupeol ; Monogynol B; .beta.-Viscol; NCI60_042005; lup-20(29)-en-3beta-ol; Lupenol | C30H50O | 426.7 g/mol | CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)O)C)C |
| TCMBANKIN058706 | betulin | AKOS025402304; Ambotz473-98-3; betulin ; AC-7983; SCHEMBL9888462; (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13bR)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysen-9-ol; FVWJYYTZTCVBKE-MAIYTPNSSA-N; ; Trochol; 18211-63-7; C08618; Messagenin; 473-98-3; AIDS002710; B9757_SIGMA; ZINC03978650; Prestwick3_000990; Betulin; MEGxp0_001726; AI3-62999; BSPBio_001059; Lup-20(30)-ene-3beta,28-diol; C08631; Betulinol; ACon1_000091; AIDS-002710; Lup-20(29)-ene-3beta,28-diol; BPBio1_001165; Betuline; Lup-20(29)-ene-3,28-diol, (3beta)-; NSC 4644; (3.beta.)-Lup-20(29)-ene-3,28-diol; NSC692218; EINECS 207-475-5; Betulinic alcohol; ST5411404; Trochol | C30H50O2 | 442.7g/mol | CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)O)C)CO |
| TCMBANKIN058918 | (e)-4-phenyl-3-buten-2-one | NCI60_004369; Benzalacetone; 11960_FLUKA; Methyl styryl acetone; NCGC00091356-01; 2-Phenylvinyl methyl ketone; Acetocinnamone; Benzylidene acetone (natural); 3-BUTEN-2-ONE, 4-PHENYL-, (E)-; WLN: 1V1U1R; trans-4-Phenyl-3-butene-2-one; Benzylidene acetone; 4-Phenyl-3-buten-2-one; 122-57-6; trans-Benzylidenacetone; EINECS 217-587-6; 4-Phenyl-3-butene-2-one; Methyl styryl ketone; trans-4-Phenylbut-3-en-2-one; Styryl methyl ketone; InChI=1/C10H10O/c1-9(11)7-8-10-5-3-2-4-6-10/h2-8H,1H3/b8-7; 241091_ALDRICH; Methyl beta-styryl ketone; NSC 5605; 4-phenylbut-3-en-2-one; 2-07-00-00287 (Beilstein Handbook Reference); Methyl .beta.-styryl ketone; 3-BUTEN,2-ONE,4-PHENYL (TRANS) BENZALACETONE; (E)-4-Phenyl-3-buten-2-one; Methyl 2-phenylvinyl ketone; ZINC01589953; Benzalaceton [German]; 1896-62-4; Ketone, methyl styryl; T5396015; trans-Benzylideneacetone; Benzalaceton; W288101_ALDRICH; AI3-52291; Methyl trans-styryl ketone; (E)-4-phenylbut-3-en-2-one; trans-Benzalacetone; Benzylideneacetone; NSC5605; EINECS 204-555-1; FEMA No. 2881; trans-4-Phenyl-3-buten-2-one; CCRIS 5319; BRN 0742047; ghl.PD_Mitscher_leg0.147; (3E)-4-phenylbut-3-en-2-one; 4-Phenylbutenone; Benzilidene acetone; 4-07-00-01003 (Beilstein Handbook Reference); AI3-00944; Benzilideneacetone; BRN 0742046; 3-Buten-2-one, 4-phenyl-; 147885_ALDRICH; (E)- benzylidene acetone; benzylideneacetone; TPBO; BWHOZHOGCMHOBV-UHFFFAOYSA-N; CJ-16027; (3E)-4-Phenylbut-3-en-2-one (Benzalacetone); W-109036; 2-Phenylvinyl methyl ketone; DSSTox_GSID_31626; A813340; Benzylidene acetone (natural); DSSTox_CID_11626; MolPort-004-288-302; t-PBO; 4-Phenyl-(E)-3-Buten-2-one; (E)-Benzylideneacetone; Benzalacetone, analytical standard; DSSTox_RID_78888; 3-Buten-2-one, 4-phenyl-, (3E)-; AKOS000119902; (E)-4-Phenyl-3-buten-2-one; LS-666; MP-2122; 1-Phenyl-1-buten-3-one; SCHEMBL312972; MFCD00008779; benzylideneacetone, (Z)-isomer; trans-4-Phenyl-3-buten-2-one, >=99%; Benzylideneacetone; TC-172858; BWHOZHOGCMHOBV-BQYQJAHWSA-N; Benzilideneacetone; RL01029; METHYL STYRYL KETONE (SEE ALSO METHYL STYRYL KETONE (1896-62-4)); Methyl styryl acetone; NCGC00091356-01; W-107746; 3-BUTEN,2-ONE,4-PHENYL (TRANS) BENZALACETONE; (E)-1-Buten-3-one, 1-phenyl; WLN: 1V1U1R; DTXSID1031626; Tox21_301598; SCHEMBL76632; TPBO; Epitope ID:120383; KB-47903; 4-Phenyl-3-butene-2-one; DB-003136; SMR001252234; 4-Phenyl-3-buten-2-one, 99%; Benzylideneacetone, >=98%, FG; AC1LCUWK; Methyl .beta.-styryl ketone; AN-22878; STK803195; 1896-62-4; Ketone, methyl styryl; UNII-B03X40BMT5; (E)-4-phenylbut-3-en-2-one; FT-0083233; (e)-3-buten-2-on; 4-PHENYL-2-BUTENONE; CCRIS 5319; (E)-Benzalacetone; E-4-phenyl-3-buten-2-one; ghl.PD_Mitscher_leg0.147; AK116927; B03X40BMT5; Benzilidene acetone; 4-07-00-01003 (Beilstein Handbook Reference); NCGC00255323-01; 4-PHENYL-3-BUTEN-2-ONE; METHYL TRANS-STYRYL KETONE (SEE ALSO METHYL STYRYL KETONE (122-57-6)); AN-50066; 3-Buten-2-one, 4-phenyl-; DS-4780; RTC-069523; trans-4-phenyl-but-3-en-2-one; I01-10159; trans-4-Phenyl-3-butene-2-one; AB1011458; ST51052045; EINECS 217-587-6; AJ-72632; A804921; (E)-Methyl Styryl Ketone; Methyl styryl ketone; Benzalacetone; Benzylideneacetone; Methyl styryl ketone; BENZ; InChI=1/C10H10O/c1-9(11)7-8-10-5-3-2-4-6-10/h2-8H,1H3/b8-7; Methyl beta-styryl ketone; fema 2881; NSC 5605; Methyl (E)-2-Phenylethenyl Ketone; Methyl 2-phenylvinyl ketone; CHEBI:78399; Benzalaceton [German]; MLS002454416; NCGC00091356-02; P0163; trans-Benzylideneacetone; Benzalaceton; Methyl trans-styryl ketone; EINECS 204-555-1; LS-958; FEMA No. 2881; BRN 0742047; (3E)-4-phenylbut-3-en-2-one; ST2411593; I01-5963; BRN 0742046; methyltrans-styrylketone; Benzalacetone; EC 204-555-1; Acetocinnamone; 3-BUTEN-2-ONE, 4-PHENYL-, (E)-; HMS2268K18; Benzylidene acetone; Jsp003898; 122-57-6; trans-Benzylidenacetone; NSC-5605; CHEBI:217301; AK107621; Warfarin Impurity (Benzalacetone); BBL012455; trans-Phenylvinyl Methyl Ketone; MolPort-001-779-702; CAS-1896-62-4; trans-4-Phenylbut-3-en-2-one; Styryl methyl ketone; trans-1-Phenylbut-1-en-3-one; F0001-0357; 2-07-00-00287 (Beilstein Handbook Reference); 3-BUTEN,2-ONE,4-PHENYL (TRANS) BENZALACETONE; CHEMBL73639; (E)-4-Phenyl-but-3-en-2-one; Methyl beta -STYRYL ketone; RP21073; benzylideneacetone, (E)-isomer; 4-Phenylbut-3-en-2-one; AI3-52291; trans-Benzalacetone; (3E)-4-Phenyl-3-buten-2-one; Benzalaceton (german); NSC5605; ZINC19230125; trans-4-Phenyl-3-buten-2-one; 4-Phenylbutenone; KB-47501; AI3-00944; TC-069523; 1-Buten-3-one-1-phenyl | C10H10O | 146.19 g/mol | CC(=O)C=CC1=CC=CC=C1 |
| TCMBANKIN058930 | 3',4'-dihydroxyacetophenone | FT-0633465; A1-00828; Acetopyrocatechol; 1-[3,4-bis(oxidanyl)phenyl]ethanone; MFCD00016439; ANW-17366; CHEBI:69446; UNII-07OQ35LVBK; AJ-24297; 631D869; CJ-04514; FT-0693227; MCULE-9501549860; SC-67020; CC-13184; Pungenol; Qingxintong; Dihydroxyacetophenone; 98%; CD-457; BC220893; 07OQ35LVBK; 3',4'-Dihydroxyacetophenone; dihydroxyacetophenone,3,4-; 4-Acetocatechol; DTXSID30152546; CHEMBL243161; AN-48842; SCHEMBL144106; 1-(3,4-Dihydroxyphenyl)ethanone, 9CI; 4-Acetylpyrocatechol; 4-Acetopyrocatechol; SBB061719; AC1L2410; C-03021; PubChem3384; UCQUAMAQHHEXGD-UHFFFAOYSA-N; Ethanone,1-(3,4-dihydroxyphenyl)-; ST45102395; 1-(3,4-Dihydroxyphenyl)-Ethanone; CS-W008953; D2345; AE-641/00345018; C10675; 3,4-DIHYDROXYACETOPHENONE; ZB015173; 1-acetyl-3,4-dihydroxybenzene; CHM0022688; 4-acetylcatechol; 3/',4/'-Dihydroxyacetophenone; Ethanone, 1-(3,4-dihydroxyphenyl)-; FCH917098; AKOS002231977; CHEBI:19868; 1-(3,4-Dihydroxyphenyl)ethanone #; 1-(3,4-dihydroxyphenyl)ethan-1-one; 1197-09-7; I14-30850; GS-3459; AK-42350; AB0014212; 3,4'-dihydroxyacetophenone; ZINC900177; KB-28318; 1-(3,4-Dihydroxyphenyl)ethanone; Acetylpyrocatechol; A804342; ACM28631869; K418; 4CN-2675; J-004179; RTR-003294; CTK4B1452; TD1322; ACMC-1CIQZ; OR345013; LS-67369; MolPort-000-154-542; Acetophenone-3',4'-dihydroxy; AX8011148; TR-003294; ST24026855;3,4-dihydroxyacetophenone | C8H8O3 | 152.15 g/mol | CC(=O)C1=CC(=C(C=C1)O)O |
| TCMBANKIN058950 | Benzoylacetone | 2-Propanone, benzoyl-; ST5197366; B11907_ALDRICH; Acetoacetophenone; 1-Phenyl-1,3-butanedione; Acetylbenzoylmethane; .alpha.-Acetylacetophenone; 1-Benzoyl-2-propanone; 1,3-BUTANEDIONE,1-PHENYL BENZOYLACETONE; AI3-10572; Benzoyl-aceton [German]; NSC100655; EINECS 202-286-4; InChI=1/C10H10O2/c1-8(11)7-10(12)9-5-3-2-4-6-9/h2-6H,7H2,1H; NSC4015; alpha-Acetylacetophenone; 4-07-00-02151 (Beilstein Handbook Reference); 1,3-Butanedione, 1-phenyl-; 1-Phenylbutane-1,3-dione; 1-Phenyl-1,3-butanedion; NSC 4015; BRN 0742413; 12830_FLUKA; 2-Acetylacetophenone; 93-91-4; 1-Benzoylacetone; 1-phenyl-1,3-butanedion; KS-00000C21; CVBUKMMMRLOKQR-UHFFFAOYSA-N; X6797; benzoyl acetone; BG00601093; Benzoyl-aceton [German]; SBB040798; NSC4015; 1-phenyl-butane-1,3-dione; omega-ACETYLACETOPHENONE; DSSTox_RID_76337; NSC 4015; 2-Acetylacetophenone; 2-Propanone, benzoyl-; NSC-100655; acetyl acetophenone; KB-64903; Acetylbenzoylmethane; DSSTox_CID_1803; .alpha.-Acetylacetophenone; ST24038177; AC1Q5F12; STR01075; MCULE-5543155182; alpha-Acetylacetophenone; AK161752; MolPort-000-667-917; 1,3-Butanedione, 1-phenyl-; Tox21_202879; 1-Phenyl-1,3-butanedion; MFCD00008786; UNII-I3RUV8U115; ZINC100006468; BG01501130; 93-91-4; 1-Benzoylacetone; I3RUV8U115; Benzoyl-aceton; 1-phenyl-1,3-butandione; 1-phenyl-3-butanedione; DSSTox_GSID_21803; AC1Q1K1U; B-0690; Acetoacetophenone; I01-6186; SC-23803; NCGC00260425-01; ST092313; 1-Benzoyl-2-propanone; NSC-4015; AI3-10572; CHEMBL3186793; ACMC-209ro2; ACT07622; BB_SC-0115; EINECS 202-286-4; DB-010994; 4-07-00-02151 (Beilstein Handbook Reference); RTR-030564; 1-Phenyl-1,3-butanedione, 99%; F3098-2657; PS-3611; AN-42671; 1-phenyl-butane-1,3 dione; BRN 0742413; BBL011014; TR-030564; 3-butanedione,1-phenyl-1; AC1L1O5P; NE10611; Benzoylacetone, 98% 50g; AKOS000119529; J-802021; CAS-93-91-4; SCHEMBL15116; LS-45895; ANW-40128; DTXSID3021803; NSC100655; 1-Phenyl-1,3-butanedione, purum, >=98.0% (GC); InChI=1/C10H10O2/c1-8(11)7-10(12)9-5-3-2-4-6-9/h2-6H,7H2,1H; FT-0622746; 1-Phenylbutane-1,3-dione; AB1003648; 1-PHENYL-1,3-BUTANEDIONE; Benzoylacetone; TRA0002644; STK802149 | C10H10O2 | 162.18 g/mol | CC(=O)CC(=O)C1=CC=CC=C1 |
| TCMBANKIN059272 | diisobutyl phthalate | di-isobutyl phthalate;ST5405544; diisobutyl benzene-1,2-dicarboxylate; benzene-1,2-dicarboxylic acid diisobutyl ester; Di-iso-butyl phthalate; 80130_FLUKA; Isobutyl phthalate; bis(2-methylpropyl) benzene-1,2-dicarboxylate; (C4-C13) Branched alkyl alcohols, phthalic anhydride ester; ZINC00388318; EINECS 201-553-2; NSC15316; 1,2-Benzenedicarboxylic acid, bis(2-methylpropyl) ester; Diisobutyl phthalate; 152641_ALDRICH; EINECS 273-157-8; 68951-39-3; C15205; AI3-04278; Phthalic acid, diisobutyl ester; BRN 2054802; NCGC00091360-01; NSC 15316; WLN: 1Y1&1OVR BVO1Y1&1; 4-09-00-03177 (Beilstein Handbook Reference); Diisobutylester kyseliny ftalove [Czech]; Hexaplas M/1B; 1,2-Benzenedicarboxylic acid, C4-13-branched alkyl esters; AI3-04278 (USDA); Kodaflex DIBP; 68955-80-6; Hatcol DIBP; HSDB 5247; CCRIS 6193; di-l-butyl phthalate (DIBP); Di(i-butyl)phthalate; SMR000112470; MLS000516002; 84-69-5; Palatinol IC | C16H22O4- C6H4[CO2CH2CH(CH3)2]2 | 278.34 g/mol | CC(C)COC(=O)C1=CC=CC=C1C(=O)OCC(C)C |
| TCMBANKIN059540 | WILFORLIDE A | C30H46O3 | 454.7 g/mol | CC1(C2CCC3(C(C2(CCC1O)C)CC=C4C3(CCC5(C4CC6(CC5OC6=O)C)C)C)C)C | |
| TCMBANKIN059683 | USNIC ACID | C18H16O7 | 344.32 | CC1=C(C(=C2C(=C1O)C3(C(=CC(=O)C(C3=O)C(=O)C)O2)C)C(=O)C)O | |
| TCMBANKIN059831 | Methyl atratate | C10H12O4 | 196.2 | CC1=CC(=C(C(=C1C(=O)OC)O)C)O | |
| TCMBANKIN060060 | harmine | C13H12N2O | 212.25 | CC1=NC=CC2=C1NC3=C2C=CC(=C3)OC | |
| TCMBANKIN060139 | maytenonic acid | C30H48O3 | 456.7 g/mol | CC1C(=O)CCC2C1(CCC3C2(CCC4(C3(CCC5(C4CC(CC5)(C)C(=O)O)C)C)C)C)C | |
| TCMBANKIN060140 | friedelan-3-one | C30H50O | 426.7 g/mol | CC1C(=O)CCC2C1(CCC3C2(CCC4(C3(CCC5(C4CC(CC5)(C)C)C)C)C)C)C | |
| TCMBANKIN060160 | quercitrin | C21H20O11 | 448.4 g/mol | CC1C(C(C(C(O1)OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC(=C(C=C4)O)O)O)O)O | |
| TCMBANKIN060164 | 3,4',5,7-tetrahydroxyflavone-3-l-rhamnoside | CC1C(C(C(C(O1)OC2=C3C(=CC(=C2)O)OC(=C(C3=O)O)C4=CC=C(C=C4)O)O)O)O | |||
| TCMBANKIN060264 | rutin | C27H30O16 | 610.5 g/mol | CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O | |
| TCMBANKIN060271 | acacetin-7-O-rutinoside | C28H32O14 | 592.5 g/mol | CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=CC(=C4C(=C3)OC(=CC4=O)C5=CC=C(C=C5)OC)O)O)O)O)O)O)O | |
| TCMBANKIN060313 | epifriedelinol | C30H52O | 428.73 g/mol | CC1C(CCC2C1(CCC3C2(CCC4(C3(CCC5(C4CC(CC5)(C)C)C)C)C)C)C)O | |
| TCMBANKIN060314 | epifriedelinol acetate | C32H54O2 | 1128.21 | CC1C(CCC2C1(CCC3C2(CCC4(C3(CCC5(C4CC(CC5)(C)C)C)C)C)C)C)OC(=O)C | |
| TCMBANKIN060497 | dioscin | C45H72O16 | 869.04 | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)C)O)O)O)O)OC9C(C(C(C(O9)C)O)O)O)C)C)C)OC1 | |
| TCMBANKIN060679 | stigmasterol | C29H48O | 412.7 g/mol | CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C | |
| TCMBANKIN060680 | stigmasterol-3-glucoside | C35H58O6 | 574.83 g/mol | CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C | |
| TCMBANKIN060691 | poriferast-5-en-3beta-ol;22,23-dihydrostigmasterol;gamma-sitosterol;clionasterol;beta-dihydrofucosterol | C29H50O | 414.71 g/mol | CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C | |
| TCMBANKIN060693 | Sitogluside | C35H60O6 | 576.85g/mol | CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C | |
| TCMBANKIN061153 | Octacosanol;octacosanol-1;1-octacosanol | C28H58O | 410.8 g/mol | CCCCCCCCCCCCCCCCCCCCCCCCCCCCO | |
| TCMBANKIN061253 | ethyl-2,4-dihydroxy-6-methylbenzoate;ethyl orsellinate | C10H12O4 | 196.2 g/mol | CCOC(=O)C1=C(C=C(C=C1C)O)O | |
| TCMBANKIN061448 | 7-methoxybaicalein | 5,6-dihydroxy-7-methoxy-2-phenyl-chromen-4-one; 4H-1-Benzopyran-4-one, 5,6-dihydroxy-7-methoxy-2-phenyl-; ZINC00039288; Baicalein-7-methylether; AIDS071771; ST055981; 5,6-dihydroxy-7-methoxy-2-phenyl-chromone; 29550-13-8; 5,6-dihydroxy-7-methoxy-2-phenyl-4-chromenone; AIDS-071771; 5,6-Dihydroxy-7-methoxy-2-phenyl-4H-chromen-4-one; 7-Methoxybaicalein; 5,6-dihydroxy-7-methoxy-2-phenylchromen-4-one; Negletein | C16H12O5 | 284.26 | COC1=C(C(=C2C(=C1)OC(=CC2=O)C3=CC=CC=C3)O)O |
| TCMBANKIN061520 | wogonin 5-β-d-glucoside | COC1=C(C=C(C2=C1OC(=CC2=O)C3=CC=CC=C3)O)OC4C(C(C(C(O4)CO)O)O)O | |||
| TCMBANKIN061521 | Scutevulin | 80713-32-2; 2',5,7-Trihydroxy-8-methoxyflavone; SCHEMBL5162875; 5,7-dihydroxy-2-(2-hydroxyphenyl)-8-methoxy-chromen-4-one; scutevulin; CHEMBL2235250; 5,7-dihydroxy-2-(2-hydroxyphenyl)-8-methoxy-4-chromenone; 5,7,2'-trihydroxy-8-methoxyflavone; 5,7-dihydroxy-2-(2-hydroxyphenyl)-8-methoxychromen-4-one; LMPK12111303; AC1NT0AX; 5,7-dihydroxy-2-(2-hydroxyphenyl)-8-methoxy-chromone | C16H12O6 | 300.26 | COC1=C(C=C(C2=C1OC(=CC2=O)C3=CC=CC=C3O)O)O |
| TCMBANKIN061541 | baicalein 6-methylether-7-o-β-galactopyranuro-noside | oroxylin a 7-o-glucuronide | C22H20O11 | 460.4 g/mol | COC1=C(C=C2C(=C1O)C(=O)C=C(O2)C3=CC=CC=C3)OC4C(C(C(C(O4)C(=O)O)O)O)O |
| TCMBANKIN061596 | chrysoeriol;5,7,4′-trihydroxy-3′-methoxyflavone;3'-methoxy-4',5,7-trihydroxyflavone | 35.850895 | C16H12O6 | 300.26 g/mol | COC1=C(C=CC(=C1)C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O |
| TCMBANKIN061605 | symplocoside | symplososide | C22H26O11 | 466.4 g/mol | COC1=C(C=CC(=C1)C2C(CC3=C(C=C(C=C3O2)OC4C(C(C(C(O4)CO)O)O)O)O)O)O |
| TCMBANKIN061651 | skullcapflavone i | 5,2'-Dihydroxy-7,8-dimethoxyflavone; Ambap41060-16-6; ZINC2392262; 4H-1-Benzopyran-4-one, 5-hydroxy-2-(2-hydroxyphenyl)-7,8-dimethoxy-; MolPort-035-706-534; SKULLCAPFLAVONEI; 2',5-Dihydroxy-7,8-dimethoxyflavone; 5-hydroxy-2-(2-hydroxyphenyl)-7,8-dimethoxychromen-4-one; 41060-16-6; W2788; 5-hydroxy-2-(2-hydroxyphenyl)-7,8-dimethoxy-chromone; 5-hydroxy-2-(2-hydroxyphenyl)-7,8-dimethoxy-chromen-4-one; LMPK12111304; AKOS032961992; Skullcapflavone I; panicolin; 8P86A8Q1G0; Skullcapflavone I, analytical standard; AC1NSZFT; 5-hydroxy-2-(2-hydroxyphenyl)-7,8-dimethoxy-4-chromenone; UNII-8P86A8Q1G0; SCHEMBL6069761;Panicolin | C17H14O6 | 314.29 g/mol | COC1=C(C2=C(C(=C1)O)C(=O)C=C(O2)C3=CC=CC=C3O)OC |
| TCMBANKIN061666 | oroxylin | 5,7-dihydroxy-6-methoxy-2-phenyl-4H-chromen-4-one; CTK1D7949; ZINC5998558; Oroxylin A; CHEMBL183513; 5,7-Dihydroxy-6-methoxy-2-phenyl-chromen-4-one; SC-69298; NP-005013; HY-N0560; MolPort-019-937-219; 5,7-dihydroxy-6-methoxy-2-phenyl-4H-1-benzopyran-4-one; AKOS015903364; Oroxylin-A; MFCD02259441; UNII-53K24Z586G; 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one; 6-Methoxybaicalein;; FT-0688332; Oroxylin A, >=98% (HPLC); CHEBI:61668; 5,7-dihydroxy-6-methoxyflavone; BDBM50430091; AC1NSZBG; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-6-methoxy-2-phenyl-; 5,7-Dihydroxy-6-methoxyflavone;; Y0150; I14-19006; baicalein 6-methyl ether; 53K24Z586G; DTXSID70197375; Baicalein 6-methyl ether;6-Methoxybaicalein; 480-11-5; SCHEMBL431423; LMPK12111096; Oroxylin; CS-4948 | C16H12O5 | 284.26 g/mol | COC1=C(C2=C(C=C1O)OC(=CC2=O)C3=CC=CC=C3)O |
| TCMBANKIN061667 | 5,7,4'-trihydroxy-6-methoxyflavanone | 6-Methoxynaringenin;5,7,4'-trihydroxy-8-methoxyflavanone;AC1NT16C; 5,7,4/'-Trihydroxy-6-methoxyflavanone; AK104440; 5,7-DIHYDROXY-2-(4-HYDROXYPHENYL)-6-METHOXY-2,3-DIHYDRO-1-BENZOPYRAN-4-ONE; 5,7-Dihydroxy-2-(4-hydroxyphenyl)-6-methoxychroman-4-one; AKOS022184707; 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-2,3-dihydrochromen-4-one; 5,7,4'-trihydroxy-6-methoxydihydroflavone; 6-Methoxynaringenin; 4CN-1869; 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-3,4-dihydro-2H-1-benzopyran-4-one; ST24044117; W1586; 5,7,4'-Trihydroxy-6-methoxyflavanone; 94942-49-1; LMPK12140619 | C16H14O6 | 302.28 g/mol | COC1=C(C2=C(C=C1O)OC(CC2=O)C3=CC=C(C=C3)O)O |
| TCMBANKIN061668 | dihydrooroxylin A | NCGC00180735-02!5,7-dihydroxy-6-methoxy-2-phenyl-2,3-dihydrochromen-4-one; (S)-5,7-Dihydroxy-6-methoxy-2-phenylchroman-4-one; SMR000440557; CHEBI:67376; 5,7-Dihydroxy-6-methoxyflavanone; AC1NSUL5; NP-001206; 4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-6-methoxy-2-phenyl-, (S)-; HMS2268B15; MCULE-9660679251; Flavanone, 5,7-dihydroxy-6-methoxy-; Dihydrooroxylin; MolPort-001-740-631; 5,7-dihydroxy-6-methoxy-2-phenyl-2,3-dihydro-4H-chromen-4-one; SCHEMBL12067042; LMPK12140611; QUAPPCXFYKSDSV-UHFFFAOYSA-N; MEGxp0_000455; dihydrooroxylin a; BRD-A37403959-001-01-9; 4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-6-methoxy-2-phenyl-, (2S)-; NCGC00180735-01; MLS000876753; Dihydrooroxylin A; CHEMBL1517942; ACon1_000257; 5,7-dihydroxy-6-methoxy-2-phenyl-2,3-dihydrochromen-4-one; 5-hydroxy-6-methoxyflavanone-7-O-α-D-galactopyranoside_qt; DIHYDROOROXYLIN | C16H14O5 | 286.28 | COC1=C(C2=C(C=C1O)OC(CC2=O)C3=CC=CC=C3)O |
| TCMBANKIN061740 | 2,6,2',4'-tetrahydroxy-6'-methoxychalcone;7,2',6'-trihydroxy-5-methoxychalcone | (E)-1-(2,4-dihydroxy-6-methoxyphenyl)-3-(2,6-dihydroxyphenyl)prop-2-en-1-one; AC1NT0X4 | C16H14O6 | 302.28 g/mol | COC1=CC(=CC(=C1C(=O)C=CC2=C(C=CC=C2O)O)O)O |
| TCMBANKIN061745 | syringic acid; Syryngic; 1,5-dimethoxy-3-hydroxybenzoicacid; 3,5-dimethoxy-4-hydroxybenzoic acid; Cedar acid | I01-1212; syringicacid; 3,5-dimethoxy-4-oxidanyl-benzoate; CHEBI:132111; 4-hydroxy-3,5-dimethoxybenzoate; c1409; ZB006317; AKOS015888648; A824548; A829374; CJ-01507; AC1OC351; ST51051575; C10833; DivK1c_006581; KBio3_002814; 530-57-4; AI3-24376; 3,5-Dimethoxy-4-hydroxybenzyl acid; S6881_SIGMA; BSPBio_003312; InChI=1/C9H10O5/c1-13-6-3-5(9(11)12)4-7(14-2)8(6)10/h3-4,10H,1-2H3,(H,11,12; EINECS 208-486-8; Gallic acid 3,5-dimethyl ether; Syringic acid; NSC2129; Spectrum3_001866; 4-10-00-01995 (Beilstein Handbook Reference); 4-Hydroxy-3,5-dimethoxybenzoic acid; SpecPlus_000485; NSC 2129; 4-hydroxy-3,5-dimethoxy-benzoic acid; Spectrum5_000963; ST5214746; KBio1_001525; BRN 2115262; 3,5-Dimethoxy-4-hydroxybenzoic acid; Benzoic acid, 4-hydroxy-3,5-dimethoxy- | C9H10O5 | 198.17 g/mol | COC1=CC(=CC(=C1O)OC)C(=O)O |
| TCMBANKIN061762 | syringaresinol | (+)-Suyringaresinol-di-O-beta-D-glucoside_qt; (+)syringaresinol; (+)-Suyringaresinol-di-O-beta-D-glucoside; liriodendrin_qt; dl-Syringaresinol; syringaresinol diglucoside_qt; dl-sy-ringaresinol; (+)-syringaresinol-O-β-D-glucopyranoside; (+ )-syringaresinol; 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3,5-dimethoxy-phenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan-1-yl]-2,6-dimethoxy-phenol; 21453-69-0; C10889; (7alpha,7'alpha,8alpha,8'alpha)-3,3',5,5'-tetramethoxy-7,9':7',9-diepoxylignane-4,4'-diol; CHEBI:47; 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3,5-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan-1-yl]-2,6-dimethoxyphenol; (+)-syringaresinol; (+ )- syringaresinol; dl-syringaresinol; (-)-syringaresinol; episyringaresinol; (+)-syringarosinol; (+ )-Syringaresinol-O-β-D-glucopyranoside; syringaresino; (-)-syringaresinol; (?)-syringaresinol; (+)-Syringaresinol; lirioresinol-A | C34H46O18 | 742.72 | COC1=CC(=CC(=C1O)OC)C2C3COC(C3CO2)C4=CC(=C(C(=C4)OC)O)OC |
| TCMBANKIN061798 | 7,2',6'-trihydroxy-5-methoxyflavanone | AC1NT16F; 7,2',6'-Trihydroxy-5-methoxyflavanone; 2-(2,6-dihydroxyphenyl)-7-hydroxy-5-methoxy-2,3-dihydrochromen-4-one; LMPK12140122 | C16H14O6 | 302.28 g/mol | COC1=CC(=CC2=C1C(=O)CC(O2)C3=C(C=CC=C3O)O)O |
| TCMBANKIN061828 | 5-hydroxy-4',7-dimethoxy-flavone; Flavone der. | AIDS-071717; 5-Hydroxy-4',7-dimethoxy-flavone; Genkwanin 4'-methyl ether; 5-hydroxy-7-methoxy-2-(4-methoxyphenyl)chromen-4-one; 5-Hydroxy-7-methoxy-2-(4-methoxyphenyl)-4-benzopyrone; NSC94547; Flavone, 5-hydroxy-4',7-dimethoxy- (8CI); 4H-1-Benzopyran-4-one, 5-hydroxy-7-methoxy-2-(4-methoxyphenyl)-; Flavone, 5-hydroxy-4,7-dimethoxy-; 5-Hydroxy-4',7-dimethoxyflavone; 5128-44-9; 5-hydroxy-7-methoxy-2-(4-methoxyphenyl)-4-chromenone; FLAVONE,5-HYDROXY-4-7-DIMETHOXY; AIDS071717; 5'-Hydroxy-7,4'-dimethoxyflavone; NSC 94547; C10019; Apigenin dimethylether; EINECS 225-867-4; 4',7-Dimethylapigenin; 5-Hydroxy-7,4'-dimethoxyflavone; 4H-1-Benzopyran-4-one, 5-hydroxy-7-methoxy-2-(4-methoxyphenyl)- (9CI); Apigenin 7,4'-dimethyl ether; Apigenin 4',7-dimethyl ether; Flavone, 5-hydroxy-4',7-dimethoxy-; 5-hydroxy-7-methoxy-2-(4-methoxyphenyl)chromone | C17H14O5 | 298.29 g/mol | COC1=CC=C(C=C1)C2=CC(=O)C3=C(C=C(C=C3O2)OC)O |
| TCMBANKIN061839 | 4, 4'-dimethoxy-biphenyl | 4,4'-dimethoxy-1,1'-biphenyl | C14H14O2 | 214.26 g/mol | COC1=CC=C(C=C1)C2=CC=C(C=C2)OC |
| TCMBANKIN061864 | Skullcapflavone II | CHEBI:9061; SCHEMBL3960981; 4H-1-Benzopyran-4-one, 5-hydroxy-2-(2-hydroxy-6-methoxyphenyl)-6,7,8-trimethoxy-; Skullcapflavon II; AC1L3Y1Y; NSC717846; skullcapflavone ii; MolPort-019-937-105; ZINC899074; AC1Q6AIS; DTXSID10203606; 5-hydroxy-2-(2-hydroxy-6-methoxy-phenyl)-6,7,8-trimethoxy-chromone; Neobaicalein; 5,2'-Dihydroxy-6,7,8,6'-tetramethoxyflavone; C10183; NP-016391; 5-hydroxy-2-(2-hydroxy-6-methoxyphenyl)-6,7,8-trimethoxy-4-chromenone; NSC-717846; 55084-08-7; CHEMBL465561; NCI60_040650; 5-hydroxy-2-(2-hydroxy-6-methoxy-phenyl)-6,7,8-trimethoxy-chromen-4-one; 5-hydroxy-2-(2-hydroxy-6-methoxyphenyl)-6,7,8-trimethoxy-4H-1-benzopyran-4-one; Skullcapflavone II, >=90% (LC/MS-UV); LMPK12111423; Scullcapflavone II; 5-hydroxy-2-(2-hydroxy-6-methoxyphenyl)-6,7,8-trimethoxychromen-4-one; MCULE-5710725548 | C19H18O8 | 374.34 | COC1=CC=CC(=C1C2=CC(=O)C3=C(C(=C(C(=C3O2)OC)OC)OC)O)O |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab